Covidence #,Study ID,Title,Reviewer Name,Study ID,Title,Aim of study,Study design,Study funding sources,Possible conflicts of interest for study authors,Field of application,diagnostic technique,Population description,Inclusion criteria,Exclusion criteria,Total number of studies,Outcome,N of studies of overall,N of studies with meta,N of patients in meta,Metrics:,Type of ML Used Subgroup 1,Type of ML Used Subgroup 2,Specific Algorithm Subgroup 1,Specific Algorithm Subgroup 2,Sensitivity (%) Subgroup 1,Sensitivity (%) Subgroup 2,Specificity (%) Subgroup 1,Specificity (%) Subgroup 2,Positive Likelihood Ratio Subgroup 1,Positive Likelihood Ratio Subgroup 2,Negative Likelihood Ratio Subgroup 1,Negative Likelihood Ratio Subgroup 2,Positive Predictive Value Subgroup 1,Positive Predictive Value Subgroup 2,Negative Predictive Value Subgroup 1,Negative Predictive Value Subgroup 2,Diagnostic Odds Ratio Subgroup 1,Diagnostic Odds Ratio Subgroup 2,"Area Under the Curve (AUC, in %) Subgroup 1","Area Under the Curve (AUC, in %) Subgroup 2",I2 (%) Subgroup 1,I2 (%) Subgroup 2,p-value Subgroup 1,p-value Subgroup 2,Publication Bias (%) Subgroup 1,Publication Bias (%) Subgroup 2,Dice score (%) Subgroup 1,Dice score (%) Subgroup 2,Q test Subgroup 1,Q test Subgroup 2,Accuracy Subgroup 1,Accuracy Subgroup 2,"False Positive Proportion (FPP, in %) Subgroup 1","False Positive Proportion (FPP, in %) Subgroup 2","False Negative Proportion (FNP, in %) Subgroup 1","False Negative Proportion (FNP, in %) Subgroup 2",1. Did the research questions and inclusion criteria for the review include the components of PICO,1. Did the research questions and inclusion criteria for the review include the components of PICO supporting text,2. Did the report of the review contain an explicit statement that the review methods were  established prior to the conduct of the review and did the report justify any significant deviations  from the protocol? ,2. Did the report of the review contain an explicit statement that the review methods were  established prior to the conduct of the review and did the report justify any significant deviations  from the protocol?  supporting text,3. Did the review authors explain their selection of the study designs for inclusion in the review? ,3. Did the review authors explain their selection of the study designs for inclusion in the review?  supporting text,4. Did the review authors use a comprehensive literature search strategy?  ,4. Did the review authors use a comprehensive literature search strategy?   supporting text,5. Did the review authors perform study selection in duplicate? ,5. Did the review authors perform study selection in duplicate?  supporting text,6. Did the review authors perform data extraction in duplicate? ,6. Did the review authors perform data extraction in duplicate?  supporting text,7. Did the review authors provide a list of excluded studies and justify the exclusions? ,7. Did the review authors provide a list of excluded studies and justify the exclusions?  supporting text,8. Did the review authors describe the included studies in adequate detail? ,8. Did the review authors describe the included studies in adequate detail?  supporting text,9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? RCTs ,9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? RCTs  supporting text,9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? NRSI ,9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? NRSI  supporting text,10. Did the review authors report on the sources of funding for the studies included in the review? ,10. Did the review authors report on the sources of funding for the studies included in the review?  supporting text,11. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? RCTs ,11. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? RCTs  supporting text,11. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? For NRSI ,11. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? For NRSI  supporting text,"12.  If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?  ","12.  If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?   supporting text",13.  Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review? ,13.  Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review?  supporting text,"14.  Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? ","14.  Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?  supporting text",15. If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?  ,15. If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?   supporting text,"16.  Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?","16.  Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review? supporting text"
4421,Bharati 2020,Artificial neural network based breast cancer screening: A comprehensive review,JIREGNA OLANI KEDIDA,#4421,Artificial neural network based breast cancer screening: A comprehensive review,This paper provides a systematic review of the literature on artificial neural network (ANN) based models for the diagnosis of breast cancer via mammography,Other: A Comprehensive Review,,,breast cancer,X- Ray,"The article reviews various studies that focus on the use of artificial neural network (ANN) models for the diagnosis of breast cancer via mammography. The population includes women diagnosed with breast cancer, with a focus on different types of breast tumors such as malignant (cancerous) and benign (non-cancerous) tumors.","Studies that used ANN-based models for breast cancer diagnosis.
Studies that applied different deep learning models to publicly available datasets.
Studies that used mammography as the primary diagnostic technique.
Studies that reported performance metrics such as accuracy, sensitivity, specificity, and area under the curve (AUC).","Studies that did not use ANN-based models for breast cancer diagnosis.
Studies that did not use mammography as the primary diagnostic technique.
Studies that did not report relevant performance metrics.
Studies that focused solely on segmentation and feature extraction methods without classification.",21,"For predicting breast cancer, several automated systems are already developed using different medical imaging modalities",21,17,The studies reviewed included various datasets with different sample sizes,,Radiomics,DL,"PCA-Net, CNN, DBN, SDAE, ML-NN, SNN","ResNet-50, ResNet-101, VGG16, VGG19, GoogleNet, Inception-v2, AlexNet, Faster R-CNN, YOLO, LeNet, LSTM",78.5,81.35,85.05,80.45,,,,,69.6,,86,,,,81.95,79.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3411,Marwah 2021,Artificial intelligence imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours,JIREGNA OLANI KEDIDA,#3411,Artificial intelligence imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours,"to determine the efficacy of machine learning models to differentiate treatment-related effects (TRE), consisting of pseudoprogression (PsP) and radiation necrosis (RN), and true tumour progression (TTP)",Meta analysis,"Arian Lasocki: Grant: Peter MacCallum Cancer Foundation, Comments: Arian Lasocki was supported by a Peter MacCallum Cancer Foundation Discovery Partner Fellowship",The authors declare no conflict of interest,brain cancer,MRI,"1,081 papers","(i) Differentiated either glioma or metastasis TRE (RN and/or PsP) using computational imaging features, predefined (such as radiomics) or DL-derived; 
(ii) involved treatment with radiotherapy and/or chemotherapy; 
(iii) included adequate information that met the ML processing pipeline requirements, such as imaging acquisition parameters, segmentation method, features used, ML models and classification of results through follow-up or histopathology; 
(iv) reported an AUC from a ROC curve or precision recall curve. The associated confidence interval or standard error was reported where available. If the ML processing pipeline characteristics were changed between experimentation, only the highest value was used. Only the test results (or validation) from ML models were used","Studies were excluded if they were non-peer reviewed journal articles, reviews, studies focussing on paediatric patients, opinion articles and
non-English language articles",1081,Differentiation of true tumour progression (TTP) from treatment-related effects (TRE) in brain tumours using machine learning models,25,9,,,ML,ML,"CNN, SVM, Random Forest, Logistic Regression, DL","CNN, SVM, Random Forest, Logistic Regression, DL",95.2,95.2,82.4,82.4,,,,,,,,,6.55,6.36,98,98,,,P = 0.0291,P = 0.0291,P = 0.72,P = 0.72,,,,,88.02,88.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3157,Bedrikovetski 2022,Artificial intelligence for lymph node assessment on preoperative staging in colorectal cancer: A systematic review and meta-analysis,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,Yes,,Partial Yes,,Yes,,No,,No,,Yes,,Includes only NRSI ,,Partial Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
3157,Bedrikovetski 2022,Artificial intelligence for lymph node assessment on preoperative staging in colorectal cancer: A systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#3157,Artificial intelligence for lymph node assessment on preoperative staging in colorectal cancer: A systematic review and meta-analysis,To evaluate the diagnostic accuracy of AI models used for detection of lymph node metastasis on pre-operative staging imaging for colorectal cancer,Meta analysis,"This work was supported by the Colorectal Surgical Society of Australia and New Zealand (CSSANZ) Foundation Grant and Australian Research Council Discovery Project Grant 180103232. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript",The authors declare that they have no competing interests,colorectal cancer,MRI; CT scan,"literature search of PubMed (MEDLINE), EMBASE, IEEE Xplore and the Cochrane Library for studies published from January 2010 to October 2020.",(1) included patients with histopathological diagnosis of CRC; (2) developed or used a radiomics or deep learning algorithm to assess CT or MRI pre-operative lymph node metastasis detection and (3) published in English language,"(1) case reports, review articles, editorials, letters, comments, and conference abstracts; 
(2) studies focusing on segmentation or feature extraction methods only and 
(3) animal studies",65,The quality of the studies was assessed using a modified questionnaire of the QUADAS-2 criteria. Characteristics and diagnostic measures from each study were extracted.,53,12,,,Radiomics,DL,Radiomics,CNN,77.6,88.9,67.6,93.5,,,,,,,,,,,80.8,91.7,73,0,,0.829,"No significant publication bias (Egger���s intercept 1.11, 95%CI ��� 1.22 to 3.42","No significant publication bias (Egger���s intercept 1.11, 95%CI ��� 1.22 to 3.42",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3104,Guha 2022,Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Yes,,No,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,No,,Yes,
3104,Guha 2022,Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#3104,Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis, To evaluate the deep learning & ML algorithms in classifying PCNSL from GBM,Meta analysis,,The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest,glioblastoma; brain cancer,MRI,Patients of PCNSL & GBM with pathological confirmation of disease those had  had DICOM MR images of the tumour.,All studies reporting on ML algorithms that aimed to differentiate between GBM and PCNSL on MR imaging were included.,"- Studies that compared ML with radiologists were excluded in this meta-analysis in order to maintain homogeneity, and we intend to explore this in a subsequent paper. 
- if they were commentaries, editorials, letters, or case reports Two reviewers (AG and JSG) extracted relevant data from each selected article, including study characteristics and findings of
test results using a standardized data extraction sheet that was verified independently by the third reviewer (A.M",70,"test characteristics such as accuracy, sensitivity, specificity and balanced accuracy.",10,10,1311,,ML,DL,CNN,"SVM, Random Forest, Logistic Regression",92.1,92.1,93.5,93.5,,,,,,,,,,,94.7,94.7,85,85,<0.01,<0.01,,,,,,,93.4,93.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3076,Jia 2022,Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#3076,Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis,to evaluate the diagnostic accuracy of artificial intelligence (AI) models with magnetic resonance imaging(MRI) in predicting pathological complete response(pCR) to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer,Meta analysis,,The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest,colorectal cancer,MRI; CT scan; PET-CT Scans; Other: rectal ultrasound,a total of 1873 people in the validation groups,"(1): Pathologically proven locally advanced rectal cancer patients (T3/T4 and/or N1+) 
(2); All patients received neoadjuvant chemoradiation treatment (traditional long course and trial regimens were included) 
(3); Use of MRI as the examination modality (if other imaging modalities are used, as long as MRI has been studied separately) 
(4); Predicting pathological responses in patients
 using artificial intelligence models 
(5); Provided the information necessary for the reconstruction of 2 �� 2 contingency tables 
(6); Any study design, including retrospective and prospective observational studies 
(7); the language of the publication was Eng","(1) each study had at least 10 patients 
(2) Case reports, review articles, letters, meeting reports, and editorials 
(3) Studies that included neoadjuvant chemotherapy only 
(4) Studies that included neoadjuvant radiotherapy only 
(5) Classification of patients as responsive and non-responsive, rather than pathological complete and non-pathological complete responses 
(6) No validated studies",1562,Predicting pathological complete response (pCR),90,21,1873,,Radiomics,DL,"Logistic Regression, SVM, RF, LASSO","CNN, 3D RP-Net, U-Net, TsraU-Net",77,79,74,94,3.47,11.66,0.34,0.22,,,,,,,85.38,97.24,61.9,89.5,Deek���s test: 0.20 (no publication,Deek���s test: 0.20 (no publication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2928,Kozikowski 2022,Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
2928,Kozikowski 2022,Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis,JIREGNA OLANI KEDIDA,#2928,Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis,"To systematically review the diagnostic performance of radiomic techniques
in predicting MIBC.",Meta analysis,None,None,Other: Bladder Cancer,MRI; CT scan,"Patients diagnosed with bladder cancer, specifically focusing on those with muscle-invasive bladder cancer (MIBC).", Studies that evaluated the diagnostic accuracy of radiomic models in predicting MIBC and used pathological examination as the reference standard.,"1. Machine-learning techniques were used to analyze other types of data (histopathological slides or genetic biomarkers) or 
2. Studies predict other outcomes (clinical
outcomes, lymph node metastases, and other cancer types), imaging was done in a different clinical setting (detection or BCa grading or radiotherapy planning), 
3. Studies were of
other publication types (review, conference abstracts, and
editorial), or 
4. Insufficient data were provided to calculate a contingency table",757,The summary estimates for sensitivity and specificity in predicting MIBC,8,8,860,,"SVM, LASSO","LR,RF",RFE,LR,82,82,81,81,,,,,,,,,,,88,88,,,,,Insignificant(p=0.110),Insignificant(p=0.110),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2813,Zheng 2022,Diagnostic Accuracy of Deep Learning and Radiomics in Lung Cancer Staging: A Systematic Review and Meta-Analysis,JIREGNA OLANI KEDIDA,#2813,Diagnostic Accuracy of Deep Learning and Radiomics in Lung Cancer Staging: A Systematic Review and Meta-Analysis,explore the diagnostic accuracy of the models based on deep learning or radiomics for lung cancer staging.,Meta analysis,"This work was supported by the Chengdu Science and Technology Program, Grant no. 2021007 and Sichuan Science and technology plan, Grant no. 2018JY0356",The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.,lung cancer,CT scan,74studies,"(1) patients with pathologically diagnosed lung cancer were included in the study;
(2) radiomics or deep learning algorithms applied to lung cancer staging were evaluated.","(1) informal publication types (e.g., reviews, letters to the editor, editorials, conference abstracts); 
(2) only focus on research on image segmentation or image feature extraction methods; 
(3) animal studies. ",68,Lung cancer staging accuracy,29,19,,,Radiomics,DL,"SVM, RF","CNN, TL",78.2,79,71.5,74,,,,,,,,,,,83,76.8,65.3,9.7,0.008,0.0354,,,,,,,63.8,73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2669,Xue 2023,Predictive performance of radiomics for peritoneal metastasis in patients with gastric cancer: a meta-analysis and radiomics quality assessment,JIREGNA OLANI KEDIDA,#2669,Predictive performance of radiomics for peritoneal metastasis in patients with gastric cancer: a meta-analysis and radiomics quality assessment," To systematically review the diagnostic performance of radiomic techniques 
in predicting peritoneal metastasis in patients with gastric cancer, and to evaluate the quality of current research",Meta analysis,"The authors declare that no funds, grants, or other support 
were received during the preparation of this manuscript.",The authors have no relevant financial or non-financial interests to disclose.,Other: gastric caner,CT scan,Patients with gastric cancer,"1) either prospective or retrospective 
cohort designs. 
(2) pathologically confirmed diagnosis of 
gastric cancer, with or without concurrent diagnosis of PM 
established by laparoscopy or peritoneal lavage cytology. 
(3) contrast-enhanced CT imaging performed prior to treatment. 
(4) reported sufficient data to calculate diagnostic accuracy 
measures (sensitivity, specificity) for radiomics in detecting 
peritoneal metastasis","(1) studies without available full 
text or data. 
(2) reviews, case reports, conference abstracts. 
(3) sample size<30 patients. 
(4) radiomics analysis not 
blinded. 
(5) duplicate or overlap of patient cohorts with another included study.
 (6) non-English language studies.",42,"The meta-analysis found that radiomics has strong predictive value for peritoneal metastasis in gastric cancer, but high heterogeneity and inconsistent research quality limit its clinical application.",10,10,6199,,ML,DL,"LASSO, SVM,RF","CNN, DenseNet, Inception-v3",69,86,85,92,6.5,,0.26,,,,,,25,,89,92,88,85,<0.05,<0.05,,,,,,,81,89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2421,Liu 2023,The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#2421,The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis,to evaluate the value of AI for lung cancer diagnosis,Meta analysis,"This study was supported by two national natural science foundation of China projects (grant no.32170119,31870135).The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript",The authors have declared that no competing interests exist,lung cancer,MRI; CT scan; PET-CT Scans; Other: LDSCT (Low-Dose Spiral Computed Tomography),3156 articles,"(1) Screening articles were following the STARD (The Standards for Reporting of Diagnostic Accuracy) statement; 
(2) Published literature containing AI reading of chest CTimages were used to diagnose lung cancer; 
(3) AI was used to read chest CT images with precise diagnostic results; 
(4) The specificity and sensitivity of AI reading chest CT images for
 the diagnosis of lung cancer is based on pathology testing as the gold standard","(1) literature for which complete data and duplicates are not available;
(2) literature for which pathology testing is not the gold standard; 
(3) literature for which case studies, reviews, animal studies, reviews, abstracts, etc. are available",3156,Diagnostic accuracy of AI-assisted lung cancer diagnosis,469,14,"5,251",,AI,AI,"SVM, ANN, RF, CNN, fuzzy neural network, manifold regularized classification deep neural network","SVM, ANN, RF, CNN, fuzzy neural network, manifold regularized classification deep neural network",87,87,87,87,6.5,6.5,0.15,0.15,,,,,43,43,93,93,85.91,88.5,0,0,P = 0.33,P = 0.33,,,177.38,217.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2014,Badran 2022,Automated brain tumour identification using magnetic resonance imaging: a systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#2014,Automated brain tumour identification using magnetic resonance imaging: a systematic review and meta-analysis,"This study systematically evaluated the performance of automated brain tumor detection and segmentation methods, and assessed the quality of reporting using the Checklist for Artificial Intelligence in Medical Imaging guideline",Meta analysis,"This work was supported by the SINAPSE innovation fund. The funders had no role in study design, analysis, and interpretation, or writing",The authors declare no conflicts of interest,brain cancer,MRI," We searched PubMed, Web of Science, and Scopus for studies published between January 1, 2000, and May 8, 2021. ",Studies were included if they developed or validated a semi-automatic or fully automatic adult brain tumor detection or segmentation method using MRI.,"(1) studies reporting tumor classification or tumor grading methods only; 
(2) studies utilizing MRI spectroscopy only for method development; 
(3) studies reporting methods on pediatric, pituitary, and/or brainstem tumors only; 
(4) abstracts or conference proceedings; and 
(5) no performance metrics reported",1515,"We evaluate the performance of traditional machine learning (TML) and deep learning (DL) in brain tumor detection and segmentation, using MRI",224,84,,,DL and TML,DL and TML,"ResNet, VGG, DenseNet, U-Net, and custom CNN models","ResNet, VGG, DenseNet, U-Net, and custom CNN models",98,84,96.5,85,,,,,,30.6,,,,,0.98,0.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1987,Lin 2024,MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,No,,No,,No,,Partial Yes,,Partial Yes,,Partial Yes,,Yes,,Yes,,Yes,,Yes,,No,,Yes,,Yes,,Yes,
1987,Lin 2024,MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific,JIREGNA OLANI KEDIDA,#1987,MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific,"To evaluate the quality of existing models, discuss their inherent limitations, and outline potential future directions",Meta analysis,Funding sources were not involved in the study design,All authors declare that there is no conflict of interest,breast cancer,MRI,2467 studies,radiomics with breast MRI and predicted treatment outcomes with potential implications for surgical planning following neoadjuvant therapy in breast cancer patients. Only original articles published in English were selected,#NAME?,2467,To evaluate the predictive performance of radiomics and deep learning models,51,40,304,,DL,DL,"SVM, RF, AdaBoost, LR, CNN, U-net, Delta-radiomics","SVM, RF, AdaBoost, LR, CNN, U-net, Delta-radiomics",78,84,87,86,,,,,,,,,,,87,88.5,79,75,0.01,0.01,,,,,,,88,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1951,Chen 2024,Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,Yes,,Yes,,Yes,,Yes,,No,,Yes,,Yes,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
1951,Chen 2024,Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#1951,Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis,To assess the diagnostic accuracy of machine learning (ML)-based radiomics for predicting isocitrate dehydrogenase (IDH) mutations in patients with glioma,Meta analysis,Youth Science and Technology Fund Program of Science and Technology Department of Gansu Province (21JR11RA071),The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest,brain cancer,MRI,Patients diagnosed with gliomas,"1) patients with pathologically confirmed glioma; 
2) histopathological examination with the IDH mutation as a reference standard; 
3) sufficient data for the reconstruction of 2��2 tables in terms of the diagnostic performance of MR-based radiomics in predicting the IDH of glioma; and 
4) original research arti","1) each study had at least 10 patients;
 
2) reviews, case reports, letters, and editorials; 

3) studies not focusing on the diagnostic performance of MR-based radiomics in predicting IDH mutations; and
 
4) insufficient data for the reconstruction of 2��2 table studies with overlapping cohorts. Two authors, C. X.L and Z.J, independently evaluated the eligibility of the included articles, and any disagreements were resolved via discussion with a third author (W.S.W, with 10 years of experience in neuroimagi",642,Diagnostic performance of radiomics in predicting IDH mutations in gliomas.,14,14,1740,,ML,DL,"SVM, RFC,LOgistic regression",CNN,83%,77%,84%,91%,5,,25,,,,,,25,,90,,79.6,74.07,0,0,,,,,63.72,50.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1811,Chen 2024,Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
1811,Chen 2024,Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy,JIREGNA OLANI KEDIDA,#1811,Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy,to systematically review and perform a meta-analysis of the diagnostic accuracy of machine learning models that incorporate multimodal features to predict radiation pneumonitis in lung cancer patients,Meta analysis,"Natural Science Foundation of Chongqing, China, CSTB2023NSCQ-MSX0059.
Chengdu Longquanyi district health committee medical topic Program of Chengdu, China, WJKY2024010.
The Project of Chongqing Technology Innovation and Application 
Development,China, No.CSTC2021jscxgksb-N0022",The authors declare no competing interests.,lung cancer,CT scan,"A total of 1,406 patients with primary lung cancer were included in this systematic review, drawing data  from 9 studies. ","Study Type: Published diagnostic studies on machine learning models using multi-modal features to predict RP.
Subjects: Patients with primary lung cancer, including non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC).
Data Completeness: Studies providing complete diagnostic data (true positive (TP), false positive (FP), false negative (FN), and true negative (TN)).
ML Algorithm Integration: Machine learning algorithms using at least two relevant modalities (e.g., clinical data, blood factors, radiomics, dosimetry).
Model Validation: Models trained and tested on independent internal or external test sets.
Study Design: Prospective or retrospective.
Participants: Adult subjects.
Language: Full-text publications in English.","Summaries, letters to the editor, case reports, conference abstracts, and animal studies.
Studies focusing on metastatic pulmonary malignancies.
Studies lacking complete diagnostic data or independent model validation",284,"The primary outcomes, including combined sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic 
odds ratio (DOR), and area under the curve (AUC)",40,9,1406,,ML,ML,"SVM, SVC, LR, GNB, BNB, KNN, DT, RF","SVM, CNN, RF, LR, GNB, BNB, KNN, DT",75,65,92,90,9,6.61,0.28,0.39,,,,,36.75,16.95,93,89,56.5,23.36,,,,,,,18.39,10.44,94,83.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1807,Ying 2025,Accuracy of machine learning in diagnosing microsatellite instability in gastric cancer: A systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#1807,Accuracy of machine learning in diagnosing microsatellite instability in gastric cancer: A systematic review and meta-analysis,"To ascertain whether ML can emerge as a 
novel screening modality for detecting MSI in GC.",Meta analysis,Mingxian Chen,"The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper.",Other: gastric cancer,Other: pathological imaging,Patients diagnosed with Gastric cancer,"(1) 
Studies on patients diagnosed with GC via biopsy;
(2) 
Studies that have fully developed ML models for MSI 
identification;
(3) 
Some studies lacked an independent validation set; however, 
their contribution cannot be disregarded. Consequently, studies 
without any external validations were also included.
(4) 
Case-control/cohort studies, cross-sectional studies;
(5) 
Studies that were published in English","(1) Meta-analyses, reviews, expert opinions, guidelines, etc.;
(2) Studies that exclusively conducted differential factor analysis but no comprehensive ML model was constructed;
(3) Original research lacking outcome measures of ML model pre��dictive accuracy (e.g., ROC, c-statistic, c-index, accuracy, sensi��tivity, specificity, recall, precision, and confusion",466,The study evaluates the accuracy of machine learning (ML) models in diagnosing microsatellite instability (MSI) in gastric cancer through a systematic review and meta-analysis.,20,12,11912,,DL,ML,"CNN, ResNet, DenseNet",,86,77,83,81,,,,,,,,,,,86,87,,,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1673,Long 2024,Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis,JIREGNA OLANI KEDIDA,#1673,Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis,"To evaluate the diagnostic accuracy of
magnetic resonance imaging (MRI) based radiomic features for predicting
epidermal growth factor receptor (EGFR) mutation status in non-small cell
lung cancer (NSCLC) patients with brain metastases",Meta analysis,"The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article","The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a potential conflict of interest",lung cancer,MRI,"Non-small cell lung cancer
patients diagnosed with brain
metastases","1) studies published in
peer-reviewed journals; 
2) studies performed in patients with NSCLC and diagnosed with brain metastases; 
3) studies related to the diagnostic accuracy of MRI-based radiomics features for
predicting EGFR mutation status; 
4) adequate data to calculate
sensitivity, specificity, PLR, NLR and AUC; 
5) validated methods
for identification of EGFR mutation status confirmed by tissue biopsy or molecular testing, and 
6) publications in English
or Chinese.","1) conference abstracts, case
reports, letters, editorials, or review articles; 
2) focused solely on
non-diagnostic outcomes or therapeutic interventions; 
3) lacking
essential data required for analysis; 
4) duplicates or overlapping
datasets from the same study population; and 5) not accessible in
full-text format.",Non-small cell lung cancer (NSCLC) patients diagnosed with brain metastases.,,48,13,"2,348",,ML,ML,Logistics regression,Random Forest,83,72,75,92,3.46,7.73,0.26,0.31,,,,,13.31,24.86,91,91,63.1,35.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1645,Gouravani 2025,Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
1645,Gouravani 2025,Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#1645,Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis,"use of artificial intelligence (AI) for the detection of RCC to quanti
tatively determine the performance of AI for distinguishing related renal lesions",Meta analysis,Not applicable,The authors declare no competing interests,Other: kidney cancer,MRI; CT scan,Sixty-four studies were included in this systematic review,"All of the original human research studies that developed or validated an AI algorithm to detect RCC amid other renal lesions or compared to healthy controls meeting following PICOS criteria were included without any publication time, or study setting limitations. P: Patients with RCC; I: Image analysis based on AI algorithm; C: Benign renal lesions or healthy controls; O: Performance metrics such as sensitivity, specificity, accuracy, etc.; S; Single studies, comparative studies, and original studies on humans","(1) non-original articles
(2) non-English articles",64, Evaluate of the diagnostic performance of utilized algorithms,31,31,248,,AI,AI,"CNN, Res-UNet, YOLOv7, DL, Radiomics, Transfer Learning, Neural Networks, Texture Analysis, Patch-based CNN, Quantitative Texture Analysis, Automated Differentiation, Binary Classification, Multiphase CT, MRI Radiomics, HSROC","CNN, Res-UNet, YOLOv7, DL, Radiomics, Transfer Learning, Neural Networks, Texture Analysis, Patch-based CNN, Quantitative Texture Analysis, Automated Differentiation, Binary Classification, Multiphase CT, MRI Radiomics, HSROC",85,80,75,90,3.5,7.8,0.2,0.23,,,,,17,34,88,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1622,Mohammadzadeh 2025,Can we rely on machine learning algorithms as a trustworthy predictor for recurrence in high-grade glioma? A systematic review and meta-analysis,JIREGNA OLANI KEDIDA,#1622,Can we rely on machine learning algorithms as a trustworthy predictor for recurrence in high-grade glioma? A systematic review and meta-analysis,"to assess the effectiveness and accuracy of AI algorithms in predicting the likelihood 
of recurrence in patients with HGG",Meta analysis,The authors did not receive support from any organization for the submitted work,The authors declare no competing interests,glioblastoma,MRI; CT scan,Patients with high-grade glioma (HGG) undergoing diagnostic assessment using machine learning algorithms,"1) Original articles such as cohort studies, randomized clinical trials and case-series 
2) Conducted on patients diagnosed with HGG, 
3) Reporting all type of ML 
algorithms; i.e., Random Forest (RF), convolutional Neural Network 
(DNN), Decision Tree (DT), K-nearest neighbors (KNN), Support Vector 
Machine (SVM) in predicting recurrent HGG","1) non-original articles, such as reviews, editorials, or case reports; 
2) Involving cases of glioma classified as low-grade (Grade I, II); 
3) The exact grade of the glioma is not specified; 
4) Lacking sufficient data or outcomes related for prediction of recurrence; and 
5) Research not using ML algorithms for prediction of recurrence",1077,Diagnostic accuracy of machine learning algorithms in predicting recurrence of high-grade glioma,7,5,533,,ML,ML,SVM,"CNN, RF, DT",95,87,80,77,4.75,,0.06,,,,,,,80.97,,,59.06,0,0.04,0.47,,,,4.39,9.77,3.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1190,Nguyen 2018,Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#1190,Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis,to evaluate the implementation of ML algorithms in differentiating GBM and PCNSL,Meta analysis,,The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper,glioblastoma,MRI,article 1081,if they utilized ML algorithms and aimed to differentiate between GBM and PCNSL on radiological imaging," if they were commentaries, editorials, letters, or case reports",article 1081,"test characteristics such as accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC)",8,8,1600,,ML,Radiologists,"SVM, Random Forest, ANN, k-NN, Decision Tree, LDA, Naive Bayes",,80,77,90,88,,,,,,,,,,,93.45,80.8,,,p = 0.252,p = 0.257,,,,,,,92.1,74.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1108,Zhao 2020,Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.,JIREGNA OLANI KEDIDA,#1108,Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.,"To assess the diagnostic accuracy of machine learning (ML) in predicting isocitrate dehydrogenase (IDH) mutations
in patients with glioma and to identify potential covariates that could influence the diagnostic performance of ML",Meta analysis,Supported by a grant from the Natural Science Foundation of Guangdong Province (2017A030313676),"he authors of this manuscript declare no relationships with any companies, whose products or services may be related to
the subject matter of the article.",brain cancer,MRI,patients with glioma ,"a) patients with histopathologically confirmed WHO grade II, III, or IV gliomas; 
(b) a reference standard based on immunohistochemical analysis for IDH1 mutation (R132H) or genomic sequencing analysis for IDH1 and IDH2 genes; 
(c) ML was applied to classify the IDH mutation status; 
(d) sufficient information for the reconstruction of 2 �� 2 tables for determination of the diagnostic sensitivity and specificity of ML for prediction of IDH-mutated gliomas;
(e) original research arti","(a) had a small sample size(less than ten); 
(b) used ML to classify the IDH mutation status, but did not focus on the diagnostic accuracy of ML in predicting IDH mutation; and 
(c) included overlapping patient cohorts",116,Diagnostic accuracy of AI models for predicting IDH mutations in gliomas using MRI based imaging.,9,9,996,,DL,DL,"CNN, SVM","RF, CNN",87,83,88,85,7.24,5.58,0.15,0.18,,,,,49.35,,93,89,85.81,73.72,0.001,0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1084,Cuocolo 2020,Machine learning for the identification of clinically significant prostate cancer on MRI: a meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,Yes,,Partial Yes,,Yes,,No,,No,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,,,Yes,,Yes,,Yes,
1084,Cuocolo 2020,Machine learning for the identification of clinically significant prostate cancer on MRI: a meta-analysis.,JIREGNA OLANI KEDIDA,#1084,Machine learning for the identification of clinically significant prostate cancer on MRI: a meta-analysis,To determine the diagnostic performance of combined radiomics and ML in the detection of csPCa,Meta analysis,The authors state that this work has not received any funding,The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article,prostatic cancer,MRI,"Multiple medical databases were systematically searched for studies on ML applications in csPCa identification up to July 31, 2019.","(1) an analysis focused on csPCa identification, defined as a Gleason score (GS) ��� 3 + 4, was presented; 
(2) information on area under the receiver operating characteristic curve (AUC) and total number of positive and negative cases, respectively defined as csPCa and non-csPCa lesions or patients included in the analysis, were reported; 
(3) an outcome of the ML on csPCa identification was provided; 
(4) clear definition of the dataset used in the study and input data source. When lesions were analysed separately based on transition (TZ) or peripheral zone (PZ) location, the results from both models were in","Studies that did not use ML or presented insufficient data for pooling were not included. Reviews, editorials, abstracts, animal studies, conference presentations or studies on diagnostic performance were excluded",60,ML pipelines using prostate MRI to identify csPCa,12,12,,,DL,DL,"LAD tree, Na��ve Bayesian, Linear regression, Random forest, Logistic regression, Convolutional neural network, Support vector machine, Artificial neural network, Deep transfer lear","LAD tree, Na��ve Bayesian, Linear regression, Random forest, Logistic regression, Convolutional neural network, Support vector machine, Artificial neural network, Deep transfer lear",85,88,79,76,,,,,,,,,,,85,88,87,93,< 0.0001,> 0.0001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1037,Wu 2022,Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy.,JIREGNA OLANI KEDIDA,#1037,Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy,to comprehensively evaluate the accuracy and effectiveness of ultrasound imaging based on artificial intelligence algorithms in predicting lymph node metastasis in breast cancer patients through  a meta-analysis.,Meta analysis,"The authors have received no financial support for the research, authorship, or publication of this manuscript. ","None of the authors have any personal, financial, commercial, or academic conflicts of interest. ",breast cancer,Ultrasonography, 10 articles involving a total of 4726 patients,"1) Study participants: breast cancer patients; 
2) Interventions and comparators: a comparison of AI imaging with pathological diagnosis of lymph node metastasis (pathology as the reference standard); 
3) Outcome measures: the primary outcome was the area under the receiver operating characteristic curve (AUC), and secondary outcomes included sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio; 
4) Study design: cohort studies or case-control studies; 
5) Language: restricted to English","1) Duplicate studies: studies with identical data
2) Irrelevant study types: animal studies, case reports, literature reviews, or conference abstracts
3) Studies with incomplete data or not reporting the specified outcomes, including studies that analyzed all stroke events rather than the subtype of ischemic stroke",188,"area under the receiver operating characteristic curve (AUC), and secondary outcomes included sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio",14,10,4726,,DL,non AI,"Genetic Algorithm, SVM, CNN",,88,88,75,76,3.5,3.3,0.16,0.29,,,,,23,11,89,84,84.68,91.11,<0.001,<0.001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1011,Ugga 2021,"Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis.",JIREGNA OLANI KEDIDA,#1011,"Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis",to analyze the methodological quality of prospective and retrospective studies published on radiomics analyses of intracranial meningiomas.,Meta analysis,,"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.",brain cancer,MRI; CT scan,256 articles,those evaluating the grading of meningioma through ML were selected to perform a meta-analysis.,"Case reports, nonoriginal investigations (e.g., editorials, letters, reviews), and studies not focused on the topic of interest",256,A meta-analysis of machine learning studies for the preoperative evaluation of meningioma grading was performed and their risk of bias was assessed with the Quality Assessment of Diagnostic Accuracy Studies tool,23,8,,,ML,ML,"LDA, Logistic Regression, SVM, RF, XGBoost	","SVM, RF, Logistic Regression",,,,,,,,,,,,,,,88,88,42.17,88.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1010,Badrigilan 2021,Deep learning approaches for automated classification and segmentation of head and neck cancers and brain tumors in magnetic resonance images: a meta-analysis study.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,No,,No,,Partial Yes,,Yes,,No,,No,,Yes,,No,,No,,Yes,,No meta-analysis conducted ,,No,,No,,No,,No,,No,,Yes,
1010,Badrigilan 2021,Deep learning approaches for automated classification and segmentation of head and neck cancers and brain tumors in magnetic resonance images: a meta-analysis study.,JIREGNA OLANI KEDIDA,#1010,Deep learning approaches for automated classification and segmentation of head and neck cancers and brain tumors in magnetic resonance images: a meta-analysis study,"we aimed to evaluate the performance of the DL models for the segmen-
tation and classification of MRI data of patients with HNCs and brain tumors.",Meta analysis,This work was supported by the Kermanshah University of Medical Sciences [Grant numbers 990688],"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.",brain cancer; Other: Head and Neck,MRI,"PubMed, Web of Science, Embase, and Scopus were searched to retrieve related studies published from January 2016 to January 2020","Studies that evaluated the performance of DL-based models in the segmentation, and/or classification and/or grading of HNCs and/or brain tumors were included. ","a) reviews, conference abstracts, book chapters, meta-analysis, editorials, duplicate publication, 
b) lacking sufficient data regarding diagnostic estimates such as true positives (TP), false negatives (FN), true negatives (TN), false positives (FP), sensitivity, and specificity, c) inability to obtain the full text.",1459,A statistical analysis was conducted using the above data to analyze the performance of DL methods for head and neck tumor segmentation and classification. ,109,30,,,DL,DL,"CNN, U-Net, DeepMedic, SegNet, VGG-19","CNN, U-Net, DeepMedic, SegNet, VGG-19",97,97,98,95,42,19,0.04,0.04,,,,,,,99,98,,,,,,,89.65,0.8395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1008,Bedrikovetski 2021,Artificial intelligence for the diagnosis of lymph node metastases in patients with abdominopelvic malignancy: A systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Yes,,No,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
1008,Bedrikovetski 2021,Artificial intelligence for the diagnosis of lymph node metastases in patients with abdominopelvic malignancy: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#1008,Artificial intelligence for the diagnosis of lymph node metastases in patients with abdominopelvic malignancy: A systematic review and meta-analysis,This review assesses the diagnostic performance of deep learning algorithms and radiomics models for lymph node metastases in abdominopelvic malignancies.,Meta analysis,,T. Sammour and S. Bedrikovetski would like to acknowledge the support of the SA Health eHealth Innovation Grants Program (2019- 00421 / A1418479). G. Maicas and G. Carneiro would like to acknowledge the support by the Australian Research Council grant DP180103232. ,bladder cancer; cervical cancer; endometrial cancer; ovarian cancer; uterine body cancers; liver cancer; colorectal cancer,MRI; CT scan,"Embase (PubMed, MEDLINE), Science Direct and IEEE Xplore databases were searched to identify eligible studies published between January 2009 and March 2019.","All original studies assessing radiomics models or deep-learning al��
gorithms to analyse CT or MRI images with the purpose of detecting LN metastases in patients with abdominopelvic organ malignancy were included. Abdominopelvic organs were defined as: liver, gallbladder, kidneys, spleen, pancreas, stomach, small bowel, colon, rectum, bladder, and internal reproductive organs. The search was limited to studies published in English langua","Studies focused on segmentation and feature extraction methods only, case reports, editorials, letters, meta-analysis, comments, mini-reviews, book chapters and all confer��ence which did not include complete data were exclud",58,Study characteristics and diagnostic measures were extracted,21,17,,,Radiomics,DL,"SVM, radiomics, evidential reasoning",CNN,73,86.7,56.6,75,,,,,56.1,72,73.4,87.8,,,69.7,91.2,77,,0.005,,,,,,,,63.7,79.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1002,Sohn 2020,Diagnostic Accuracy of Machine Learning-Based Radiomics in Grading Gliomas: Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#1002,Diagnostic Accuracy of Machine Learning-Based Radiomics in Grading Gliomas: Systematic Review and Meta-Analysis.,"To estimate the diagnostic accuracy of machine learning- (ML-) based radiomics in differentiating high-grade gliomas (HGG) from low-grade gliomas (LGG) and to identify potential covariates that could affect the diagnostic accuracy of
ML-based radiomic analysis in classifying gliomas.",Meta analysis,NA,The authors declare that they have no conflicts of interest,brain cancer,MRI,"Patients with histopathologically confirmed WHO grade
gliomas including both lower-grade glioma and high-grade glioma","(a) original research articles;
(b) patients with histopathologically confirmed WHO grade
gliomas including both lower-grade glioma and high-grade
glioma;
 (c) ML-based with radiomics features that were applied to classify gliomas using radiomics features; and
(d)information for reconstructing 2 �� 2 tables to estimate the diagnostic sensitivity and specificity for grading gliomas was
inclu"," (a) they did not use ML to classify the grade of gliomas; 
(b) did not focus on differentiating between LGG and HGG; 
(c) no replies were re-
ceived from the authors after requesting the data related to
reconstructing the 2 �� 2 table or subgroup analysis; and 
(d) they had a small sample size for performing the machine
learning classi",215,ML-based radiomics achieves excellent diagnostic accuracy in differentiating high-grade gliomas (HGG) from low-grade gliomas (LGG),5,5,629,,Classical ML,Classical ML,"SVM, LR, RF","SVM, RF",96,94,90,97,9.53,12.91,0.07,0.05,,,,,153.85,176.99,96,97,69.7,80.2,<0.01,<0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1000,Castaldo 2021,Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Partial Yes,,Includes only RCTs,,Yes,,Yes,,No,,Yes,,No,,Yes,,Yes,,Yes,
1000,Castaldo 2021,Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review.,JIREGNA OLANI KEDIDA,#1000,Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review,to suggest an integrated estimate of the accuracy for use of ML algorithms in detecting PCa through a systematic review and meta-analysis of the available studies,Systematic review,This work was supported by ���Progetti di Ricerca Corrente��� funded by the Italian Ministr,None declared,prostatic cancer,MRI,"816 titles were identified from the PubMed, Scopus, and OvidSP databases",If machine learning was fully applied in distinguishing individuals or lesions with clinically diagnosed PCa from controls and if the study assessed the accuracy of such applications,"We limited the search to English-only studies; although this is
 common in systematic reviews, this exclusion criterion could
 have reduced the generalizability of the findings. However, the
 extent and effects of language bias have recently diminished
 because of a shift toward publication of studies in English",816,Multivariate meta-analysis via the HSROC model was assessed for all the studies,37,29,,,"ML, DL","ML, DL","ANN, LDA, RF, SNCSAE, LR, DCNN, CNN, LASSO LR, DNN, SVM, CART","LR, RF, SVM, CNN",87.7,91.94,87.82,89.22,,,,,,,,,,,81.5,82.8,84,74,0,0.006,,,,,,,81.5,82.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
998,Jian 2021,Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#998 ,Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis., To evaluate the diagnostic accuracy of machine learning (ML) models in molecular subtyping gliomas on preoperative magnetic resonance imaging (MRI).,Meta analysis,This study did not receive any funding or financial support.,"The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article",glioblastoma,MRI,508 articles,"(1) aimed to predict at least 1 of 8 aforementioned molecular markers using any MRI sequence; 
(2) utilized an ML algorithm for classification;
(3) included patients with histopathologically confirmed glioma of any WHO grade; 
(4) contained sufficient information to reconstruct 2 �� 2
tables (we contacted authors if this was insufficient); and 
(5) English langua"," (1) commentaries, editorials,
letters, review articles, case reports, conference abstracts, or (2) animal studies.",508,Diagnostic accuracy of ML models in predicting molecular markers in glioma on MRI,227,44,,,ML,Radiologists,"SVM, CNN, RF",,88,,86,,,,,,,,,,,,92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
971,Buchlak 2021,Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,Yes,,No,,No,,Partial Yes,,Includes only NRSI ,,Yes,,No,,,,No,,Yes,,Yes,,No,,No,,Yes,
971,Buchlak 2021,Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review.,JIREGNA OLANI KEDIDA,#971,Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review,"(1) systematically review machine learning methods and tools applied to glioma MRI data, 
(2) analyse article characteristics and impact, and 
(3)
explore the application of NLP methods to the corpus.",Systematic review,,The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper,glioblastoma,MRI,"The search resulted in the retrieval of 15,001 records. We assessed 536 full text articles; 337 were excluded, which left 153 studies for analysis","Original research published in a peer-reviewed journal; involved the use of one or more sequences of MRI neuroimaging data (e.g., T1, T2, T1CE, FLAIR); included adult patients diagnosed with high- or low-grade glioma; published in English; and involved the application of machine learning techniques for outcome classification or prediction. Included articles were limited to those published within the last 10 years to focus on methodologies applied within the era of deep learning","If a study involved the use of multivariate logistic regression, but not as a classifier, it was excluded. Studies that relied primarily on Cox regression and fuzzy methods were excluded.",490,"A machine learning study was defined here as one that employed an algorithm to predict or classify one or more outcomes and involved the use of one or more of the following performance metrics: accuracy, area under the receiver operating characteristics curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), F1 score or Dice similarity coefficient (DSC).",490,153,,,ML,ML,"CNN, SVM, RF","CNN, SVM, RF",87,87,86,86,,,,,88,95,85,83,,,71,71,,,,,,,81,81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
930,Bedrikovetski 2021,Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#930,Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.,"To evaluate the accuracy of AI models in diagnosing lymph node metastasis on CT and/or MRI in colorectal
cancer patients.",Systematic review,"The Colorectal Surgical Society of Australia and
New Zealand (CSSANZ) Foundation Grant and Australian Research Council Discovery Project Grant 180103232. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in
writing the manuscript.",The authors declare that they have no competing interests,colorectal cancer,MRI; CT scan,,"(1) included patients with histopathological diagnosis of CRC; 
(2) developed or used a radiomics or deep learning algorithm to assess CT or MRI pre-operative lymph node metastasis detection and (3) published in English language","(1) case reports, review articles, editorials, letters, comments, and conference ab-stracts; 
(2) studies focusing on segmentation or feature
extraction methods only and 
(3) animal studies.",68,"Summary estimates of sensi-tivity, specificity and AUROC were produced with 95% confidence intervals on a per-patient and per-nodal basis.",17,12,,,"Radiomics, DL","Radiomics, DL","Radiomics, CNN(DP)",Radiomics,,,,,,,,,,,,,,,80.8,91.7,,,,,,73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
917,Hickman 2022,Machine Learning for Workflow Applications in Screening Mammography: Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#917,Machine Learning for Workflow Applications in Screening Mammography: Systematic Review and Meta-Analysis,To evaluate the reported performance of standalone ML applications for screening mammography workflow,Meta analysis,,"S.E.H. research collaborations with Meran-tix, ScreenPoint, Volpara, and Lunit. R.W. employee of University of Cambridge.E.P.V.L. no relevant relationships. Y.R.I. no relevant relationships. C.M.L. no relevantrelationships. A.I.A.R. no relevant relationships. G.C.B. no relevant relationships.J.W.M. employee of Astra Zeneca. F.J.G. funding from Lunit; consultant for Alpha-bet and Kheiron; payment or honoraria for lectures, presentations, speakers bureaus,manuscript writing, or educational events from GE Healthcare; president of EuropeanSociety of Breast Imaging; equipment, materials, drugs, medical writing, gifts, or otherservices from GE Healthcare, Bayer, Lunit, and ScreenPoint",breast cancer,Other: CAD,"an estimated 185 252 cases from three countries with more than 39 readers were included in the pri
mary meta-analysis","women imaged with mam
mography for screening or diagnosis of breast cancer and a 
ML algorithm applied as stand-alone workflow application 
(ie, CAD and CADx or CADt) with sufficient information re
ported for the performance of stand-alone ML algorithms and 
reader performance, or the simulated impact on reader per
formance and workflow to allow for comparison",,7233,A primary meta-analysis included the top-performing algorithm and corresponding reader performance from which pooled summary estimates for the area under the receiver operating characteristic curve (AUC) were calculated using a bivariate model,32,15,185252,,"CAD, CADx, CADt","CAD, CADx, CADt","ResNet-18, ResNet (V2 50 and V1 50), MobileNetV2, RetinaNet, InceptionResNetV2, Transpara, Lunit, Customized CNN, Ensemble CEM, VGG, Faster R-CNN","ResNet-18, ResNet (V2 50 and V1 50), MobileNetV2, RetinaNet, InceptionResNetV2, Transpara, Lunit, Customized CNN, Ensemble CEM, VGG, Faster R-CNN",75.4,73,90.6,88.6,,,,,,,,,,,89,85,0.3,0.3,0.11-0.40,0.11-0.40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
898,Koong 2022,Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis.,JIREGNA OLANI KEDIDA,#898,Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis.,To identify future directions for application of ML in sellar tumor MRI.,Meta analysis,NA,No conflicts of interest,brain cancer,MRI,"patients with sellar tumors, including pituitary neuroendocrine tumors (PitNETs), meningiomas, and gliomas. It also includes pediatric cohorts with adamantinomatous craniopharyngiomas (ACP).","1. Studies utilizing machine learning (ML) or deep learning (DL) algorithms for MRI radiomics analysis of sellar tumors.
2. Studies published between 2010 and September 2021.

3. Studies retrievable in English.","1. Case studies, reviews, abstracts, commentaries, theses, proceedings, and books
2.  Studies which did not publish data specific to sellar region masses or pit-
NETs
3. Studies with no imaging/not related to MRI/radiomics
4. Studies with no AI
5. Studies which do not including sellar region/ not reporting sellar region data/other conditions
6. Full text not retrievable in English
 ",2638,"The study evaluates the diagnostic and prognostic capabilities of ML and DL algorithms in analyzing MRI radiomics for sellar tumors, highlighting high sensitivity, specificity, and classification accuracy.",58,31,233,,ML,DL,SVM,CNN,87.9,100,95.3,99.6,,,,,,,,,,,,,,,,,,,,,,,91.2,99.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
870,Anderson 2022,Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,as objectives .but there is no search question,Yes,,Yes,,Partial Yes,,Yes,,Yes,,Yes,,Yes,,Includes only NRSI ,,Partial Yes,,Yes,,Yes,,No,,No,,Yes,,Yes,,,,Yes,
870,Anderson 2022,Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review.,JIREGNA OLANI KEDIDA,#870,Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review,"We aimed to summarize the current state of the science regarding independent external validation of artificial intelligence (AI) technologies for screening mammography using real-world clinical data and whether the evidence is of high enough quality for widespread 
clinical adoption. ",Systematic review,,"CIL and DSMB are co-authors of one paper included in this systematic review. CIL receives personal fees from GRAIL, Inc. for service on a data safety monitoring board and from the American College of Radiology for journal editorial board work.

Corresponding author: Christoph Lee, MD, MS, 825 Eastlake Avenue East, G2-600, Seattle, WA 98109, Phone: 206-606-6783; 
stophlee@uw.edu, 
 .
HHS Public Access Author manuscript J Am Coll Radiol. Author manuscript; available in PMC 2023 February 01. Published in final edited form as: J Am Coll Radiol. 2022 February ; 19(2 Pt A): 259���273. doi:10.1016/j.jacr.2021.11",breast cancer,X- Ray,"We searched Embase, PubMed, IEEE Explore, Engineer Village, and Arxiv databases from inception through December 10, 2020",Studies that used screening mammography exams from real-world clinical settings to independently evaluate AI algorithm cancer detection accuracy were included. ,"We excluded AI algorithm evaluation studies that only used publicly available datasets (e.g., DDSM, mini-Mammographic Image Analysis Society (MIAS) database, Optimam Mammography Database), as these datasets have been heavily used in training and developing AI algorithms. Similarly, we excluded studies that involved internal AI algorithm validation using a subset of the original cohort used to train and develop the algorithms, as such exercises are known to suffer from model overfitting.",160,"The main outcomes of interest were overall accuracy as defined by the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of AI algorithms for breast cancer detection on real-world screening mammography cohorts.",66,25,"148,361",,Radiomics,DL,CNN,CNN,93%,93,98%,98,,,,,,,,,,,84%,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
857,Xue 2022,Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#857,Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis.,"To assess the
diagnostic performance of deep learning (DL) algorithms for early breast and cervical cancer identification. ",Meta analysis,CAMS Innovation Fund for Medical Sciences (Grant #: CAMS 2021-I2M-1-004).,The authors declare no competing interests,cervical cancer; breast cancer,"MRI; Other: Mammography, Ultrasound, Cytology, Colposcopy",Patients tested for breast and cervical cancer ,"Studies that reported the diagnostic
performance of a DL model/s for the early detection of breast or cervical
cancer using medical imaging. Studies reporting any diagnostic outcome,
such as accuracy, sensitivity, and specificity etc., could be included. There
was no restriction on participant characteristics, type of imaging modality
or the intended context for using DL models.
Only histopathology was accepted as the study reference standard. ","Imperfect ground truths, such as expert opinion or consensus, and
other clinical testing were rejected. Likewise, medical waveform data or
investigations into the performance of image segmentation, 
Animals��� studies or non-human samples are excluded and duplicates are rem",2252,The study found that deep learning (DL) algorithms demonstrated strong diagnostic performance in detecting breast and cervical cancer using medical imaging,35,20,,,CNN,DNN,"ResNet, VGG, DenseNet","Inception-v3, EfficientNet",89,88,85,84,,,,,,,,,,,93,92,97.65,99.9,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
856,Booth 2022,Imaging Biomarkers of Glioblastoma Treatment Response: A Systematic Review and Meta-Analysis of Recent Machine Learning Studies.,JIREGNA OLANI KEDIDA,#856,Imaging Biomarkers of Glioblastoma Treatment Response: A Systematic Review and Meta-Analysis of Recent Machine Learning Studies,"To systematically review and perform a
meta-analysis of diagnostic accuracy of ML-based treatment response monitoring biomarkers for glioblastoma patients using recently published peer-reviewed studies",Meta analysis,"This research was supported by the Wellcome/EPSRC Centre for Medical Engineering (WT 203148/Z/16/Z) (TB, MG, AC, MM, SO) which includes open access fees, The Royal College of Radiologists (TB) and King���s College Hospital Research and Innovatio",The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.,glioblastoma,MRI,"we extracted articles from MEDLINE, EMBASE and Cochrane Register between 09/2018���01","Adult glioblastoma patients treated with a standard care regimen (maximal debulking surgery, followed by radiotherapy with concomitant temozolomide, followed by adjuvant temozolomide) who underwent follow-up imaging to determine treatment response status (explicitly, differentiating true progression/recurrence from mimics of progression/recurrence (defined below), and designated as the target condition of the systematic review).","Studies were excluded if they focused on pediatrics, pseudoresponse, or had no ML algorithm employed in the extraction or selection of features, or in classification/regression",,Monitoring biomarkers using machine learning (ML) may determine glioblastoma treatment response.,57,10,1719,,DL,DL,"LASSO, 3D CNN, mRMR, DC-AL GAN, imagenet_vgg_f, Gabor dictionary, SRC, Linear Discriminant Analysis","LASSO, 3D CNN, mRMR, DC-AL GAN, imagenet_vgg_f, Gabor dictionary, SRC, Linear Discriminant Analysis",76.9,76.9,35.2,35.2,2.22,2.22,0.366,0.366,,,,,6.67,6.67,76.5,76.5,,,0.017,0.017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
846,Zhang 2022,Diagnostic Accuracy of Artificial Intelligence Based on Imaging Data for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#846,Diagnostic Accuracy of Artificial Intelligence Based on Imaging Data for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.,"To assess the diagnostic accuracy of AI algorithms for non-invasive, preoperative
prediction of MVI based on imaging data",Meta analysis,NA,"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.",liver cancer,MRI; CT scan; Ultrasonography,patients with hepatocellular carcinoma (HCC) undergoing preoperative imaging for microvascular invasion (MVI) prediction using artificial intelligence models.,"1) population: pathologically confirmed HCC patients after surgical resection;
2) intervention: evaluation of MVI using AI algorithms based on quantitative imaging data preoperatively; 
3) outcome: diagnostic accuracy of imaging analysis for diagnosing or predicting MVI in HCC study; and 
4) design: any type of study design, including
observational studies (retrospective or prospective) and clinical trials.","1) studies with duplicate patients and data; 
2) case reports, review articles, letters, conference abstracts, and editorials; and 
3) studies not in the field of interest.",2280,summary receiver operating characteristic curve and the area under the curve (AUC) were generated to assess the diagnostic accuracy of the deep learning and non-deep learning models.,16,16,4759,,DL,Non deep learning,"CNN, 3D-CNN","SVM,LR,RF",84,77,84,77,5.14,3.3,0.2,0.3,,,,,,,90,82,85.81,73.72,<0.001,0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
843,Liang 2022,Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Partial Yes,,No,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
843,Liang 2022,Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#843,Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.,To determine the diagnostic accuracy of machine learning (ML) models with MRI in predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer. ,Meta analysis,,"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence 
the work reported in this paper.",breast cancer,MRI,Patients with breast cancer who underwent neoadjuvant chemotherapy (NAC),"a) Patients were confirmed as having breast cancer and were treated with neoadjuvant therapy; b) the language of the publication was English; 
c) The ML algorithm applied to MRI that was used to assess patient response to NAC was provided; 
d) Pathological assessment of tissues resected 
after breast cancer surgery served as the reference standard; 
e) Each 
study had at least 10 patients; f) the articles were peer-reviewed; and 
g) The studies were required to report AUC values, standard deviations, 95% confidence intervals (CIs), and standard errors. ","a) The patient had other types of primary cancer concurrent with breast cancer; 
b) The patient had distant metastases from breast cancer; and 
c) Articles types were comments, abstracts, case reports, or editorial materials.",188," ML + MRI showed high accuracy (AUC = 0.87, 95% CI = 0.84���0.91) in predicting response to neoadjuvant th",20,17,3392,,ML,DL,"RF, SVM",CNN,85,92,82,88,,,,,,,,,,,85,92,84.5,66.9,0.009,0.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
800,Potipimpanon 2022,A comparison of artificial intelligence versus radiologists in the diagnosis of thyroid nodules using ultrasonography: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#800,A comparison of artificial intelligence versus radiologists in the diagnosis of thyroid nodules using ultrasonography: a systematic review and meta-analysis,"The primary objective of this systematic review and meta-analysis was to accumulate the pooled sensitivity and specifcity between all available AI and the radiologists using thyroid US imaging. 
The secondary objective was to compare AI���s diagnostic performance to that of radiol",Meta analysis,"No funds, grants, or other support was received.",No confict of interest to be disclosed. The authors have no relevant fnancial or non-fnancial interests to disclose.,thyroid nodules,Ultrasonography,3735 articles retrieved from searching the database.,"(1) participants had their thyroid US performed by radiologists and AI using the reference standard in accordance with clinical practice guidelines, including surgical pathology, FNA or follow up US 
(2) the number of thyroid nodules, the true positive, true negative, false positive and false negative, sensitivity and specifcity were provided","(1) not written in English 
(2) lacked sufcient 
data to generate the contingency table 
(3) case reports or review articles.",3735,The primary outcome is the pooled sensitivity and specificity of AI compared to radiologists in diagnosing thyroid nodules.,25,3,,,AI,AI (Radiologist),"CNN, DCNN, ANN, SVM, RF","CNN, DCNN, ANN, SVM, RF",86,85,78,82,,,,,,,,,23.1,27.12,89,91,96.14,96.42,0.56,0.56,Assessed using Deek���s Funne,Assessed using Deek���s Funne,,,621.67,670.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
799,Kouli 2022,Automated brain tumor identification using magnetic resonance imaging: A systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,No,,Partial Yes,,Yes,,Yes,,No,,Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
799,Kouli 2022,Automated brain tumor identification using magnetic resonance imaging: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#799,Automated brain tumor identification using magnetic resonance imaging: A systematic review and meta-analysis.,"To valuate the 
performance of traditional machine learning (TML) and deep learning (DL) in brain tumor detection and segmentation, using MRI.",Meta analysis,"This work was supported by the SINAPSE innovation fund. The 
funders had no role in study design, analysis, and interpretation, or writing",The authors declare no conflicts of interest.,brain cancer,MRI,Adult populations with brain tumors studied using semi-automatic or fully automatic detection and segmentation methods.,"Studies were included if they developed or validated a 
semi-automatic or fully automatic adult brain tumor detection or segmentation method using MRI. ","(1) studies reporting tumor classification or tumor grading 
methods only; 
(2) studies utilizing MRI spectroscopy only 
for method development;
 (3) studies reporting methods on 
pediatric, pituitary, and/or brainstem tumors only; 
(4) abstracts or conference proceedings; and 
(5) no performance 
metrics reported",2389,"Deep Learning (DL) achieved superior performance compared to Traditional Machine Learning (TML) in brain tumor detection, evidenced by a significantly lower false positive rate (FPR: 0.018 vs. 0.048, P < .001), and in tumor core segmentation, where DL achieved a higher Dice Similarity Coefficient (0.80 vs. 0.63, P < .001)",224,84,,,Dl,TML,NN,,98,98,98.2,95,,,,,,,,,,,,,99.9,99.9,<0.001,,,,80,63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
790,Hanis 2022,Diagnostic Accuracy of Machine Learning Models on Mammography in Breast Cancer Classification: A Meta-Analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,No,,No,,No,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
790,Hanis 2022,Diagnostic Accuracy of Machine Learning Models on Mammography in Breast Cancer Classification: A Meta-Analysis.,JIREGNA OLANI KEDIDA,#790,Diagnostic Accuracy of Machine Learning Models on Mammography in Breast Cancer Classification: A Meta-Analysis,to estimate the diagnostic accuracy of machine learning models on digital mammograms and tomosynthesis in breast cancer classification and to assess the factors affecting its diagnostic accuracy,Meta analysis,"This research was funded by the Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia (FRGS/1/2019/SKK03/USM/02/1)",The authors declare no conflict of interest,breast cancer,MRI,2897 research articles were identified in the 5 databases,#NAME?,"-Peer-reviewed research articles, proceedings, and theses.
-Articles that compared feature extraction and segmentation methods.
-Articles that had ensembles or hybrid machine learning models as classifiers.
-Three-class prediction models unless a 2x2 confusion matrix was reported.",2897,"The overall diagnostic accuracy of the machine learning model in the form of the AUC and the hierarchical summary receiver operating character
istics (HSROC) curve. The secondary outcomes were the result of a likelihood ratio test for variables��� classifier, country of the data, source of data and type of the",189,36,,,ML,DL,"Neural Network (NN), Support Vector Machine (SVM), Deep Learning (DL), Gaussian Mixture Model (GMM), Tree-based Model, k-Nearest Neighbor (KNN), Bayes-based Model, Logistic Regression","Neural Network (NN), Support Vector Machine (SVM), Deep Learning (DL), Gaussian Mixture Model (GMM), Tree-based Model, k-Nearest Neighbor (KNN), Bayes-based Model, Logistic Regression",83,83,84,84,,,,,,,,,28.34,28.34,90,90,,,0.016,0.016,p = 0.002,p = 0.002,,,,,90,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
778,Karabacak 2022,"Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.",Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
778,Karabacak 2022,"Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.",JIREGNA OLANI KEDIDA,#778 ,"Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.
"," To evaluate the diagnostic performance of deep learning (DL) to determine IDH
mutation status in gliomas.",Meta analysis,None,The authors have no conflicts of interest to declare,glioblastoma; brain cancer,MRI,,"(I) patients with histopathologically confirmed World Health Organization (WHO) grade II, III, or IV gliomas; 
(II) histopathological examination with the IDH mutation; 
(III) DL was applied to predict the 
IDH mutation status; 
(IV) sufficient data for reconstruction of confusion matrices (2��2 tables) in terms of the diagnostic performance of the DL algorithms; 
(V) original research artic","I) reviews, letters, guidelines, editorials, 
or errata; 
(II) ML was applied to predict the 
IDH mutation 
status; 
(III) IDH mutation status was not predicted; 
(IV) insufficient data for the reconstruction of confusion 
matrices; 
(V) studies with overlapping cohorts",54,"The diagnostic performance of DL algorithms for predicting IDH mutation status in gliomas was evaluated, showing high sensitivity, specificity, and post-test probabilities.",4,4,1295,,DL,DL,Residual Neural Network,"Convolutional Neural Network
",93.9,90.8,90.9,85.5,,,,,97.6,96,27,30.6,206.607,53.2,95.8,93.9,87.2,38.8,<0.01,0.55,,,,,11.71,4.31,High,High,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
770,Zhong 2022,An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics.,JIREGNA OLANI KEDIDA,#770,An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics,To update the systematic review of radiomics in osteosarcoma,Meta analysis,"This study has received funding by Yangfan Project of Science and Technology Commission of Shanghai Municipality (22YF1442400); Shanghai Science and Technology Commission Science and Technology Innovation Action Clinical Innovation Field (18411953000); Medicine and Engineering Combination Project of Shanghai Jiao Tong University (YG2019ZDB09); and Research Fund of 
Tongren Hospital, Shanghai Jiao Tong University School of Medicine (TRKYRCXX202204, 2020TRYJ(LB)06, 2020TRYJ(JC)07, TRGG202101, TRYJ2021JC06). They played no role in the study design, data collection or analysis, decision to publish, or manuscript preparation",The authors declare that they have no competing interests,Other: Bone cancer (osteosarcoma),MRI; CT scan; X- Ray,33 models described in the 29 included studies,"All primary research assessing the role of radiomics in osteosarcoma treatment for diagnostic, prognostic, or predictive purposes was considered eligible for the current review",,251,Predicting malignancy risk in CT-detected pulmonary nodules,29,4,115,,DL,,"RF, SVM, nnU-Net",,84,,85,,5.43,,0.19,,,,,,28.83,,91,,42.04,,0.16,,0.035,,,,5.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
746,Xu 2022,Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#746,Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis.,,Meta analysis," Funded by the Natural Science Founda-
tion of China, the LiaoNing Revitalization Talents Pro-
gram, and the 345 Talent Project of Shengjing Hospital of China Medical University.","It were discussed with a third collaborator
(F-HL).",ovarian cancer,MRI; CT scan; Ultrasonography,patients who underwent medical imaging for ovarian cancer diagnosis,"The Medline, Embase, IEEE, Pubmed, Web of Science,
and the Cochrane library,
for studies that developed an AI algorithm for the diagnostic performance of OC from medical imaging, published until August 1, 2022. Only English-language
articles were considered. Supplementary Note 1 summa-
rizes the search strategy used in each database.
Eligible studies reported the AI technologies for
the diagnosis of OC from medical radiology images
with diagnostic outcomes, such as sensitivity (SE),
and specificity (SP), or detailed information on 2��2
contingency ta","duplicate publications; reviews; editorials;
non-human samples; histopathology images; combining non-image information; no classification task;
and no AI model. ",1212,The study found that artificial intelligence (AI) algorithms demonstrated favorable diagnostic performance in identifying ovarian cancer (OC) from medical imaging.,34,28,,,ML,DL,"LR, SVM, RF","CNN, DNN",89,88,88,84,,,,,,,,,,,93,92,95.11,95.48,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
740,Liu 2023,Mammography diagnosis of breast cancer screening through machine learning: a systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,,,Yes,,Yes,,,,Yes,,,,Yes,,Yes,,No,,Yes,
740,Liu 2023,Mammography diagnosis of breast cancer screening through machine learning: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#740,Mammography diagnosis of breast cancer screening through machine learning: a systematic review and meta-analysis,to systematically review and make a meta analysis on the diagnostic accuracy of mammography diagnosis of breast cancer through various ML methods,Meta analysis,"supported by the National Natural Science Foundation of China (12171387 (MS)); China Postdoctoral Science Foundation (2018M631134 (MS), 2020T130095ZX (MS)); Young Tal
ent Support Program of Shaanxi University Association for Science 
and Technology (20210307 (MS)). The funders had no role in study 
design, data collection and analysis, decision to publish, or preparation 
of the manuscript",All authors declare that they have no competing interests,breast cancer,MRI,"A total of 32 studies with 23,804 images","Eligible studies are single-arm trials that used only machine learning methods to classify mammograms or double-arm trials that used machine learning methods and traditional manual methods to classify mammograms. The mammograms used for classification can be images obtained in retrospective studies or derived from public data sets. In addition, eligible studies should have specific data to calculate sensitivity and specificity. We only  included publications written in English","Repeated publications, non-English articles, reviews, articles that are not 
consistent with the subject of this study and articles with no clear data",5777,Diagnostic accuracy of mammography for breast cancer screening through machine learning methods,1405,32,"23,804",,ML,ML,"CNN, ANN, SVM","CNN, ANN, SVM",91.4,96.1,91.6,95,,,,,,,,,,,94.5,97.4,87,97,<0.01,<0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
724,Yang 2022,Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#724,Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis.,To conduct a systematic review and meta-analysis of deep learning (DL) models for cervical cancer CT image segmentation.,Meta analysis,This study was granted from National Natural Science Foundation of China (No. 81360220).,The authors declare that they have no competing interests.,cervical cancer,CT scan,patients undergoing CT imaging for cervical cancer segmentation,"(1) develop or validate DLs for 
segmentation of cervical cancer CT images of CTV and/ or OARs; 
(2) the article reports the structure of DLs, the size of the training set, the size of the validation set, the 
size of the test set and the DSC score of segmentation; 
(3) evaluation of segmentation results of DLs by senior 
oncologists or radiologists.  ","(1) non-deep learning models; 
(2) no relevant data reported; 
(3) animal experiments were excluded; 
(4) reviews, conference, meta-analysis, and duplicate publication",1893,"The study found that deep learning (DL) models demonstrated strong segmentation performance for cervical cancer CT images,",14,14,,,2D DL Models,3D DL Models,"U-Net, ResNet","V-Net, DenseNet",87,85,88,86,,,,,,,,,,,92,91,47.9,48.5,<0.05,<0.05,,,87,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
684,Thong 2023,Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#684,Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: A systematic review and meta-analysis,To systematically review the DTA of AI-based imaging for lung cancer screening,Meta analysis,,"The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence the work reported in this paper",lung cancer,MRI; CT scan; X- Ray; PET,"The study focuses on the diagnostic test accuracy (DTA) of AI-based imaging for lung cancer screening, involving 150,721 imaging data from 66,502 patients.",#NAME?,"- those that used phantom, histopathology, or microscopic images and non-imaging modalities; and those that investigated the accuracy of image segmentation.",4397,The pooled sensitivity for AI-based imaging for lung cancer screening,206,26,66502,,ML,DL,"SVM, ANN, PNN, Random Forest, Neural Network","CNN, 3D CNN, AlexNet, Faster R-CNN",95.2,94.4,94.5,93.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
667,Ozkara 2023,Deep Learning for Detecting Brain Metastases on MRI: A Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#667,Deep Learning for Detecting Brain Metastases on MRI: A Systematic Review and Meta-Analysis,to conduct asystematic review and meta-analysis of the performance of deep learning models that use magnetic resonance imaging (MRI) to detect BMs in cancer patients,Meta analysis,This research received no external funding.,The authors declare no conflict of interest.,brain cancer,MRI,401 studies,-patients with BMs; deep learning using MRI images was applied to detect the BMs; sufficient data were present in terms of detective performance; original research articles,"-reviews, letters, guidelines, editorials, or errata; case reports or series with less than 20 patients;
-studies with overlapping cohorts; insufficient data in terms of detective performance; machine
-learning was used to detect BMs; articles not written in English",401,Detection performance of deep learning models for identifying brain metastases on MRI�,25,24,8902,,DL,DL,"U-Net, DeepMedic, YOLOv3, Faster R-CNN","U-Net, DeepMedic, FCN",89,92,,,,,,,,,,,,,,,76,83,p < 0.01,p < 0.01,p = 0.15,p = 0.15,,,83.18,11.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
599,Yoon 2023,Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis: A Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#599,Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis: A Systematic Review and Meta-Analysis.,"To evaluate the reported standalone performances of AI for interpretation of digital mammography and digital breast 
tomosynthesis (DBT)",Meta analysis," . L.A.M. Research funding from IBM and Cepheid; consulting fees and/or honoraria from Hologic; chair of Diversity and Inclusion Committee, Maryland Radiological Society.",".H.Y. No relevant relationships. F.S. Grants or 
contracts from Region Stockholm and Swedish Breast Cancer Association; speaker fees 
from Lunit. P.A.T.B. Secretary general and executive board member of European Society 
of Breast Imaging (EUSOBI). E.F.C. Grants or contracts from iCAD, OM1, National 
Institutes of Health (NIH), and National Cancer Institute; consulting fees from iCAD; 
lecture payments from Hologic, MedScape, and Aunt Minnie; meeting and/or travel 
support from the RSNA; University of Pennsylvania patents planned, issued, or pend-
ing; leadership role at Society of Breast Imaging. F.J.G. Grants or contracts from Lunit, 
Bayer, Hologic, and GE Healthcare; consulting fees from Alphabet and Kheiron; lecture 
payment and receipt of equipment from GE Healthcare; president, EUSOBI. C.D.L.
Grants or contracts from Breast Cancer Research Foundation, NIH, GE Healthcare, 
and Hologic; consulting fees from Clairity; meeting travel support from GE Healthcare, 
Hologic, and Clairity; co-founder of Clairity. E.A.M. Grants or contracts from Komen; 
lecture payments from Bayer and Guerbet; advisory board, Bracco and Kheiron; stock-
holder, Kheiron and Reveal Pharma. L.A.M. Research funding from IBM and Cepheid; 
Table 3: Meta-Regression Analysis Comparing the Diagnostic Odds Ratio for Radiologists and Standalone AI according to 
Subgroup Feature
Feature
Radiologists 
AI
�� 
SE 
P Value 
�� 
SE 
P Value
Study type
Reader study 

Historic reads 
0.81 (0.35, 1.28) 
0.24 
<.001 
1.00 (0.37, 1.62) 
0.32 
.002
Definition for negative examinations
Histopathologic finding or ���2 years FU 

Histopathologic finding or ���1 years FU 
���0.60 (���0.90, ���0.31) 0.15 
<.001 
���0.41 (���1.12, 0.31) 
0.37 
.27
���2 years FU 
���1.29 (���2.19, ���0.37) 0.46 
.01 
���0.02 (���1.09, 1.06) 
0.55 
.98
���1 year FU 
���0.38 (-0.95, 0.19) 
0.29 
.19 
���0.78 (���1.08, ���0.47) 0.16 
<.001
Not specified 
���2.56 e 
0.77 (���0.38, 1.92) 
0.59 
.19 
0.39 (���1.07, 1.85) 
0.74 
.60
Not specified 
1.58 (0.37, 2.80) 
0.62 
.01 
0.17 (���1.10, 1.43) 
0.64 
.80
Role of vendor
Involved in study design 

Not involved in study design 
1.63 (0.75, 2.51) 
0.45 
<.001 
0.96 (���0.09, 2.02) 
0.54 
.07
AI threshold
Vendor suggested 


Set at specificity of radiologist 
���0.25 (���0.53, 0.04) 
0.14 
.09 
���0.33 (���0.62, ���0.03) 0.15 
.03
Set at maximum sensitivity of radiologist 
(rule out)
���0.76 (���1.74, 0.21) 
0.50 
.13 
���1.16 (���2.32, 0.01) 
0.60 
.05
Defined for the study 
���1.19 (���1.51, ���0.86) 0.17 
<.001 
���0.73 (���1.08, ���0.37) 0.18 
<.001
Not specified 
���1.74 (���2.69, ���0.78) 0.49 
<.001 
���0.25 (���1.39, 0.86) 
0.58 
.65
Note.���Data in parentheses are 95% CIs. Reader studies are defined as studies in which radiologists interpreted mammograms for the stulting fees and/or honoraria from Hologic; chair of Diversity and Inclusion Com-
mittee, Maryland Radiological Society. R.M.N. Institutional grants or contracts from 
GE Healthcare, Koios Medical, Hologic, and iCAD; royalties from Hologic; consulting 
fees from maiData; advisory board, iCAD. N.S. Lecture payments from BARD and Ho-
logic. I.V. No relevant relationships. L.M. Editor of Radiology; grants or contracts from 
Siemens Foundation, Gordon and Betty Moore Foundation, Mary Kay Foundation, 
and Google; consulting fees from Guerbet and iCAD; meeting and/or travel support 
from British Society of Breast Radiology and European Society of Breast Imaging; board 
member of Society of Breast Imaging and International Society for Magnetic Resonance 
in Medicine; stockholder, Lunit. R.M.M. Associate editor of breast imaging for Radiology; grants or contracts from Dutch Research Council, Dutch Cancer Society, Euro-
pean Union, Siemens Healthineers, Bayer Healthcare, Beckton-Dickinson, Medtronic, 
Screen point Medical, Lunit, Koning, and PA Imaging; royalties from Elsevier; consulting fees from Bayer, Guerbet, Siemens, Screen point Medical, and Beckton-Dickinson; 
lecture payments from Siemens, Bayer, and Beckton-Dickinson; data safety monitoring board for SMALL trial; executive board member, EUSOBI; research committee 
member, ESR Advisory; editorial board member for European Radiology, advisory board 
member, Dutch Cancer Society; clinical advisory board member, Oncode Institute.
 
",breast cancer,Other: Digital mammography and digital breast tomosynthesis (DBT),women undergoing breast cancer screening using digital mammography and digital breast tomosynthesis (DBT) across multiple studies,"if they reported standalone 
performance of an AI system applied to either digital mammography or DBT to detect breast cancer and also reported independent reads by radiologists","studies using AI for triage 
only, studies only including specific populations or lesion types, studies only reporting a comparison of AI algorithms, and 
studies aimed at risk prediction rather than cancer detection.
All retrieved entries were evaluated based on the article title and abstract, first separately by two authors (J.H.Y., R.M.) and 
then in consensus. A third author (L.M.) acted as the arbitrator in case of disagreement",395,Standalone AI performed as well as or better than radiologists in mammography screening.,16,16,497091,,DL ,DL,,,80.8,75.8,76.9,95.6,,,,,,,,,,,87,89,82.89,96.03,0.002,0.152,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
596,Menon 2023,Performance of radiomics-based artificial intelligence systems in the diagnosis and prediction of treatment response and survival in esophageal cancer: a systematic review and meta-analysis of diagnostic accuracy.,JIREGNA OLANI KEDIDA,#596,Performance of radiomics-based artificial intelligence systems in the diagnosis and prediction of treatment response and survival in esophageal cancer: a systematic review and meta-analysis of diagnostic accuracy,a summary of the evidence of radiomics in esophageal cancer,Meta analysis,,,Other: esophageal cancer,CT scan; PET-CT Scans,Patients with esophageal cancer undergoing diagnostic and treatment assessment using radiomics-based AI systems,"- articles to have reported on the use of radiomics in computed tomography (CT) and PET.
- English language studies for esophageal cancers of all types were included exploring the role of radiomics in the most commonly used imaging modalities such as positron emission tomography with 2 deoxy 2-[fluorine-18] fluoro-D-glucose integrated with computed tomography (18F-FDG PET/CT) scans and CT scan
- Comparative cohort studies, non-randomized prospective studies, and RCTs","- studies reporting on the use of barium esophagograms the use of of AI in esophageal cancer but not specifically for radiomics
- case series, case reports, narrative reviews, editorials, and conference abstracts; studies without comparison groups; studies with pediatric
patients or less than five patients; and publications in a non-English language",441,"diagnostic accuracy of the imaging modality, including sensitivity, specificity, positive predictive value, and negative predictive value",50,12,473,,AI,AI,"CNN, SVM, LASSO logistic regression","SVM, CNN models, LASSO",86.5,86.7,87.1,76.1,,,,,,100,,,,,,,72,64,,,,,,,,,,79.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
562,Yang 2023,The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#562,The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.," To assess the study quality and clinical
value of machine learning and radiomic-based quantitative imaging studies for predicting the outcomes of EC patients after chemoradiotherapy",Meta analysis,"This work was supported by grants from the National Natural
Science Foundation of China [Grant No. 81872699].","The authors declare that they have no financial conflicts of
interest with regard to the content of this report.",Other: esophageal cancer,MRI; CT scan; PET; PET-CT Scans,patients with esophageal cancer ,all primary researches evaluating the role of radiomic features in EC patients treated with chemoradiotherapy for predictive or prognostic purposes.,"studies only included
quantitative imaging features of volume, PET SUV, and/or MTV,
without the inclusion of any additional engineered ���radiomics���
features; studies in phantom or animal models; reviews, technical
reports, letters to editors, comments, conference proceedings,
case reports, and articles with insufficient information for asses-
sing the methodolog",796,the study evaluates radiomics-based machine learning models for predicting chemoradiotherapy outcomes in esophageal cancer.,46,24,,,Radiomics based ML,,,,83,84,83,89,,,,,,,,,,,84,93,37.7,75.26,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
510,Lost 2023,Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.,JIREGNA OLANI KEDIDA,#510,"Systematic Literature Review of Machine Learning
Algorithms Using Pretherapy Radiologic Imaging for Glioma
Molecular Subtype Prediction",To predict molecular subtypes of gliomas from MR Imaging.,Meta analysis,National Institutes of Health/National Cancer Institute R01CA206180 and is a board member of Tau Beta Pi engineering honor society. Michael Sabel is a consultant for Novocure and Codman.,,glioblastoma,MRI,Patients with gliomas,,"1) abstract-only,
2) no application of ML reported, 3) not an original article, 
4) not published in English, 
5) no investigation of glioma/glioblastoma,
6) unrelated to MR imaging, MR spectroscopy, or PET imaging,
7) no human research subjects, and 
8) duplicates. ",12470,The study evaluates machine learning algorithms applied to pretherapy radiologic imaging for predicting glioma molecular subtypes.,85,85,,,NN,Tree based Algorithm,CNN,Random Forest,85,78,82,85,4.72,5.2,0.18,0.22,,,,,22.5,23.1,88,85,72,68,0.03,0.05,,,,,,,83,81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
497,Rokhshad 2024,Deep learning for diagnosis of head and neck cancers through radiographic data: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#497,Deep learning for diagnosis of head and neck cancers through radiographic data: a systematic review and meta-analysis,to review deep learning applications for detecting head and neck cancer (HNC) using magnetic resonance imaging (MRI) and radiographic data.,Meta analysis,"This research did not receive any specifc grant from funding agencies in the public, commercial, or not-for-proft sectors.",The authors declare that their work in this paper is not afected by competing interests or personal relationships.,brain cancer; Other: head and neck cancers,MRI; CT scan; X- Ray; PET,"HNC radiographs of human subjects including nasopharyngeal carcinoma, HNC squamous cell carcinoma, Oropharyngeal cancers, thyroid cancers, parotid tumors, esophageal cancer, parathyroid adenoma, laryngeal cancer, and lymph node;","-Population: HNC radiographs of human subjects including nasopharyngeal carcinoma, HNC squamous cell carcinoma, Oropharyngeal cancers, thyroid cancers, parotid 
tumors, esophageal cancer, parathyroid adenoma, laryngeal cancer, and lymph node;
- Intervention: Deep learning-based classifcation, detection, or segmentation of HNC.
- Comparison: Comparing the performance of deep learning models with a reference standard;
- Outcome: Diagnostic performance (accuracy, specifcity, sensitivity, area-under-the-receiver-operating-characteristics curve (AUC, degree of discrimination), F1-score (a fusion of precision and recall), receiver operating characteristic curve (ROC), mean Dice similarity coeffcient (DSC), co-occurrence, and recall on an image or pixel level)",#NAME?,1967,"Diagnostic performance (accuracy, specifcity, sensitivity, area-under-the-receiver-operating-characteristics curve (AUC, degree of discrimination), F1-score (a fusion of precision and recall), receiver operating characteristic curve (ROC), mean Dice similarity coeffcient (DSC), co-occurrence, and recall on an image or pixel level)",97,15,,,DL,DL,"Modified ResNet18, Improved Faster R-CNN, Xception, AlexNet�","Residual Attention Network, Res-U-Net, MVCNN�",91,86.84,92,78.35,,,,,,,,,103,103,96,96,90.19,97.92,0,0,"No publication bias detected, p = 0.75","No publication bias detected, p = 0.75",79.05,79.05,132.56,624.8,91.3,91.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
483,Ponsiglione 2024,Radiomics for the identification of extraprostatic extension with prostate MRI: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#483,Radiomics for the identification of extraprostatic extension with prostate MRI: a systematic review and meta-analysis,to systematically review the literature and perform a meta-analysis of MRI-based radiomics approaches for EPE prediction,Meta analysis,Open access funding provided by Universit�� degli Studi di Napoli Federico II within the CRUI-CARE Agreement. The authors state that this work has not received any fun,"Arnaldo Stanzione and Renato Cuocolo serve as Editorial Board Members of European Radiology. They have not taken part in the review or selection process of this article.
Andrea Ponsiglione serves as Editorial Board Member of Insights into Imaging. 
Andrea Ponsiglione is junior deputy editor in European Radiology. He has not taken part in the review or selection process of this article.
Renato Cuocolo serves as Editorial Board Member of European Radiology 
Experimental. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.",prostatic cancer,MRI; CT scan,260 articles,"(1) an analysis focused on EPE prediction was presented; 
(2) information on area under the receiver operating curve (AUC) and total number of positive and negative cases, respectively defned as patients with or without EPE included in the analysis, were reported; 
(3) clear defnition of the dataset used in the study and input data source. For the purposes of data pooling, in case of studies reporting data for either internal or external test-set, we considered them separately, while if diferent models were built, the one with the best predictive performance was selected.","Reviews, editorials, abstracts, animal studies, conference presentations, and studies not focused on the topic of interest, published in languages 
other than English, or presenting insufcient data for pooling",260,Diagnostic performance of MRI radiomics for predicting extraprostatic extension (EPE) in prostate cancer,14,13,,,Radiomics (non-deep ML),DL,"LASSO, SVM, Logistic Regression, Random Forest, Bayesian Network�",DLNs,,,,,,,,,,,,,,,82,72,83.7,68.4,p < 0.001,p = 0.042,Egger���s p ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
479,Wang 2024,Brain metastasis tumor segmentation and detection using deep learning algorithms: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#479,Brain metastasis tumor segmentation and detection using deep learning algorithms: A systematic review and meta-analysis,assessed the efficacy of deep learning algorithms in detecting and segmenting brain metastases from various primary origins in MRI images,Meta analysis,"Gen. & Mrs. M.C. Peng Fellowship from School of Medicine, 406 National Yang Ming Chiao Tung University, MD-SY-A3-309-01; Taichung Veterans General Hospital, TCVGHYMCT1109111; TCVGH-YMCT1119105; National Science and Technology Council in Taiwan, MOST 110-2634-F-006-022; MOST110-2221- E-A49A-504-MY3 National Yang Ming Chiao Tung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, 111W10159; BRC Plan 112W32101; Towards the 2030 Cross Domain Project for Smart Healthcare and Wellness (2/2) - SMART Plan; NSTC 111-2634-F-A49-014-; NSTC 111-2634-F-006-012; Innovative Translational Center Project 112w94002; Veterans Taiwan United University Plan 112W84700. ","The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence the work reported in this paper.",brain cancer,MRI; CT scan; PET,"The studies collectively examined 14,315 patients and reported on 65,182 metastatic lesions.","(1) It had to focus on patients with brain metastases (BMs); 
(2) Deep learning methodologies, specifically applied to MRI data, must have been used for BM segmentation and detection; 
(3) The article must have provided comprehensive 
data on the diagnostic performance of the employed deep learning algorithms; 
(4) The study design had to be original research; and 
(5) Both retrospective and prospective study designs were deemed acceptable.","(1) Reviews, letters, guidelines, editorials, or errata; 
(2) Case reports or series featuring fewer than 20 patients;
(3) Studies that presented overlapping cohorts; 
(4) Articles that lacked adequate data on the diagnostic performance of the deep learning algorithms; 
(5) Studies that employed machine learning but not specifically deep learning for BM detection; 
(6) Non-English publications; or 
(7) Studies that exclusively dealt with other types of brain tumors, without a specific focus on BMs. ",1568,The study assessed the efficacy of deep learning algorithms in detecting and segmenting brain metastases in MRI images.,42,33,65182,,DL,ML,"U-Net, DeepMedic, CNN",CNN,86.8,87,,,,,,,,,,,,,,,99.149,68.906,0.01,0.0273,,,94.6,79.3,77.168,487.113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
476,Liu 2023,Application of CT and MRI images based on an artificial intelligence algorithm for predicting lymph node metastasis in breast cancer patients: a meta-analysis.,JIREGNA OLANI KEDIDA,#476,Application of CT and MRI images based on an artificial intelligence algorithm for predicting lymph node metastasis in breast cancer patients: a meta-analysis,evaluate the accuracy and effect of computed tomography (CT) and magnetic resonance imaging (MRI) based on artificial intelligence (AI) algorithms for predicting lymph node metastasis in breast cancer patients,Meta analysis,"did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors",no competing interests,breast cancer,MRI; CT scan,"4,764 breast cancer patients","(1) breast cancer patients; 
(2) intervention vs. control based on an AI algorithm for CT or MRI imaging vs. pathologic diagnosis of lymph node metastasis (with pathology as the reference standard);
(3) the primary outcome measure was the area under the receiver operating characteristic curve (AUC), and secondary outcomes included sensitivity, specificity, positive and negative likelihood ratios and diagnostic odds ratios;
(4) the research design was cohort or case
control studies; and
(5) language restriction was English","(1) duplicate studies with similar data; 
(2) unrelated study types such as animal studies, case reports, literature reviews or conference abstracts; and
(3) studies with incomplete data or no reported set outcomes",126,"sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and area under the curve (AUC).",18,11,"4,764",,AI,AI,"SVM, RF, XGBoost, CNN, LDA, NB, KNN","Boruta, GBCl, DCNNs, DA-VGG19, DT, RF, NB, SVM, ANN, XGBoost, CNN-fast, LR",85,88,81,80,4.6,4.4,0.18,0.15,,,,,25,30,85,91,75.3,87,<0.001,<0.001,p = 0.82,p = 0.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
475,Habibi 2024,The Performance of Machine Learning for Prediction of H3K27��M Mutation in Midline Gliomas: A Systematic Review and Meta-Analy,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Yes,,Partial Yes,,Partial Yes,,,,,,Yes,,,,,,Yes,,,,Yes,
475,Habibi 2024,The Performance of Machine Learning for Prediction of H3K27��M Mutation in Midline Gliomas: A Systematic Review and Meta-Analy,JIREGNA OLANI KEDIDA,#475,The Performance of Machine Learning for Prediction of H3K27 M Mutation in Midline Gliomas: A Systematic Review and Meta-Analysis.,To comprehensively evaluate the diagnostic performance of ML-based magnetic resonance imaging radiomics in predicting H3K27 M mutation status in DMG patients.,Meta analysis,NA,The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.,brain cancer,MRI,"Patients with diffuse midline gliomas (DMGs), specifically those with confirmed H3K27M mutations, as identified through histopathology and MRI imaging.","1. English studies.
2 Studies on human.
3 Studies on patients with confirmed H3K27M-mutated glioma.
4 Studies used algorithms of ML on patients��� MRI.
5 Original articles, including cohorts, cross-sectional studies,case-control, case series, and randomized and nonrandomized clinical t","1. Non-English studies.
2 In vivo, ex vivo, and in vitro studies.
3 Studies without confirmed H3K27M-mutated glioma.
4 Studies used algorithms of ML on patients��� information rather
than MRI.
5 Case reports with and without literature review, conference abstract, book chapter, letter to editor, short communi",78,,13,6,1510,,"Random forest, SVM ","CNN, LASSO","Random Forest, SVM","CNN-SVM, LASSO",79.5,88,80,85.5,4.86,,0.11,,,,,,42.61,,84,90,71.79,,<0.01,,,,,,,,79.95,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
459,Wang 2024,Application of artificial intelligence in ultrasound imaging for predicting lymph node metastasis in breast cancer: A meta-analysis.,JIREGNA OLANI KEDIDA,#459,to explore the diagnostic accuracy of AI-assisted ultrasound imaging models in lymph node metastasis of breast cancer through meta-analysis,"to comprehensively evaluate the accuracy and effectiveness of ultrasound imaging based on artificial intelligence algorithms in predicting lymph node metastasis in breast cancer patients through 
a meta-analysis.",Meta analysis,"The authors have received no financial support for the research, authorship, or publication of this manuscript. ","None of the authors have any personal, financial, commercial, or academic conflicts of interest. ",breast cancer,Ultrasonography,Breast cancer patients evaluated for lymph node metastasis using ultrasound imaging (AI and non-AI),"1) Study participants: breast cancer patients; 
2) Interventions and comparators: a comparison of AI imaging with pathological diagnosis of lymph node metastasis (pathology as the reference standard); 
3) Outcome measures: 
the primary outcome was the area under the receiver operating char��
acteristic curve (AUC), and secondary outcomes included sensitivity, 
specificity, positive and negative likelihood ratios, and diagnostic odds 
ratio; 
4) Study design: cohort studies or case-control studies; 5) Lan��
guage: restricted to E","1) Duplicate studies: studies with identical data; 
2) Irrelevant study types: animal studies, case reports, literature 
reviews, or conference abstracts; 
3) Studies with incomplete data or not reporting the specified outcomes, including studies that analyzed all stroke events rather than the subtype of ischemic stroke.",56,"the primary outcome was the area under the receiver operating char��
acteristic curve (AUC), and secondary outcomes included sensitivity, 
specificity, positive and negative likelihood ratios, and diagnostic odds 
rat",14,13,4726,,"AI, DL",non AI,"CNN, SVM, XGBoost, Genetic Algo",ML,88,78,75,76,3.5,3.3,0.16,0.29,,,,,23,11,89,84,84.68,91.11,<0.001,,0.98,0.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
434,Bai 2024,Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,No,,Yes,,Yes,,Yes,,Yes,,Yes,
434,Bai 2024,Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#434,Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis., To systematically review and meta-analyses researches concerning the diagnostic performance of AI in detecting lymphoma using medical imaging for the first time.,Systematic review,"Discipline Construction Project of School of Population Medicine and Public Health, Chinese Academy of Medi-cal Sciences and Peking Union Medical College.",No ,Other: Lymphoma,"MRI; CT scan; PET-CT Scans; Other: Histopathology, WSI, Microscopic blood images",,"1) Any study that analyzed medical imaging for diagnosis of lymphoma with AI based models
 (2) Studies that provided any raw diagnostic performance data, such as sensitivity, specificity, area under curve (AUC) accuracy, negative predictive values (NPVs), or positive predictive values (PPVs).","(1) Case reports, review articles, editorials, letters, comments, and conference abstracts;
(2) Studies that used medical waveform data graphics material (i.e., electroencephalography, electrocardiography, and visual field data) or investigated the accuracy of image segmentation 
 rather than disease classification;
 (3) Studies without the outcome of disease classification or not target diseases; 
(4) Studies that did not use histopathology and expert consensus as the study reference standard of lymphoma diagnosis; 
(5) Studies that use animals��� studies or non human samples; 
(6) Duplicate s",1155,,30,16,,,Machine learning classifiers,Deep learning neural networks,"Logistic regression, Random forest, ","CNN, ResNet-50, VGG-16, VGG-19, ",93,86,92,94,,,,,,,,,,,97,97,91.47,99.41,0.11,0.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
397,Liu 2024,Predictive value of multiple imaging predictive models for spread through air spaces of lung adenocarcinoma: A systematic review and network meta���ana,JIREGNA OLANI KEDIDA,#397,Predictive value of multiple imaging predictive models for spread through air spaces of lung adenocarcinoma: A systematic review and network meta���an,to assess the predictive efficacy of imaging models for STAS in LUAD,Meta analysis,supported by the Clinical Medicine Science and Technology Development Foundation of Jiangsu University (grant no. JLY2021082) and Xuzhou Science and Technology Bureau (grant no. KC23229).,no competing interests,lung cancer,MRI; CT scan; PET; PET-CT Scans,"14 articles, involving 3,734 patients, and assessed 17 predictive models for STAS in LUAD","i) Study focuses on patients who have been diagnosed with LUAD and who exhibit STAS; 
ii) objective of the study is to develop a predictive model to accurately identify the presence of STAS in patients with LUAD. Tumor STAS was defined as tumor cells (micropapillary structures, solid nests, or single cells���spreading within air spaces in the lung parenchyma beyond the edge of the main tumor;
iii) patients who underwent segmental or lobar rese","i) Predictive models that were not constructed based on radiological features; 
ii) no clear inclusion and exclusion criteria; 
iii) reviews and lecture���type literature; 
iv) literature for which the full text could not be obtained and 
v) literature for which data could not be ext",565,Predicting spread through air spaces (STAS) in lung adenocarcinoma (LUAD),28,14,"3,734",,ML,ML,"ML_Peri_tumour, Features_CT, ML_Tumour, PET_CT","ML_Peri_tumour, Features_CT, ML_Tumour, PET_CT",77,70,81,83,4,4,0.28,0.36,,,,,,,86,81,17.8,20.4,,,,,,,,,10.3,56.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
357,Shrivastava 2024,Accuracy of machine learning in the diagnosis of odontogenic cysts and tumors: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#357,Accuracy of machine learning in the diagnosis of odontogenic cysts and tumors: a systematic review and meta-analysis,"to evaluate the performance of Machine Learning 
models in the detection, segmentation, and classification 
of odontogenic cysts and tumors presenting on panoramic 
(OPG) and/or CBCT radiographic images",Meta analysis,None.,The authors declare that they have no confict of interest.,breast cancer; Other: odontogenic cysts and tumors,CT scan,The study focuses on the diagnosis of odontogenic cysts and tumors using orthopantomograms (OPG) and cone-beam computed tomography (CBCT) images for a total of 319 studies.,"1. Prospective or retrospective studies published between January 2015 and December 2022 were included to review the recently updated models.
2. Studies including OPG or CBCT images of confirmed cases of odontogenic cysts or tumors
3. Studies using machine learning algorithms in the prediction of odontogenic cysts or tumors
4. Studies reporting any of the diagnostic performance metrics of the algorithm such as True Positive (TP), True Negative (TN), False Positive (FP), False Negative (FN), sensitivity, specificity, precision values, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), Intersection over Union (IoU), or F1 score which enabled estimation of accuracy of the method","1. Studies published before January 2015.
2. Studies that mentioned non-odontogenic cysts and tumors, other than that present in the jaws.
3. Studies evaluating the accuracy of the machine learning models in predicting periapical pathosis.
4. Case reports, personal opinions, letters to editors, book chapters, and narrative reviews were excluded.
5. Studies published in languages other than English were also excluded.",319,The sensitivity and specificity of machine learning models in diagnosing cysts and tumors,16,8,,,ML,ML,"DetectNet, RetinaNet, YOLOv3, Inceptionv3, DenseNet, VGG-16, MoCoV2","SVM, SDA, Inceptionv3",83,88,82,88,7.45,9.26,0.12,0.13,,,,,85.53,70.44,96.84,93.77,97.2,98.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
352,Li 2024,Application of deep learning radiomics in oral squamous cell carcinoma-Extracting more information from medical images using advanced feature analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,No,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
352,Li 2024,Application of deep learning radiomics in oral squamous cell carcinoma-Extracting more information from medical images using advanced feature analysis.,JIREGNA OLANI KEDIDA,#352,Application of deep learning radiomics in oral squamous cell carcinoma-Extracting more information from medical images using advanced feature analysis.,"To conduct a systematic review with meta-analyses to assess the recent scientific literature
addressing the application of deep learning radiomics in oral squamous cell carcinoma (OSCC)",Meta analysis,"National Natural Science Foundation of China (grant number: 82360481); Open Project of Hubei Province
Key Laboratory of Oral and Maxillofacial Development and Regeneration (grant number: 2022kqhm008); Xinjiang Postgraduate Scientific
Research Innovation Project (grant number: XJ2023G174); Xinjiang Key Laboratory of Cloud Computing Applications (grant number:2022D04061).",The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.,Other: Oral squamous cell carcinoma (OSCC),MRI; CT scan; PET-CT Scans,Patients diagnosed with oral squamous cell carcinoma (OSCC),"Patients suffered from OSCC who received chemoradiotherapy
with or without surgery were included in the study. All papers suitable for this review had to be primarily original articles that analyzed the function role of radiomics as a predictive or prognostic tool.","Review articles, conference abstracts, case series/ reports, editorial letters, correspondence, as well as other forms of publication with incomplete data or insufficient information concerning the radiomic
technique were excluded.",1508,"The advances in the application of radiomics combined with learning algorithm in OSCC were
reviewed, including diagnosis and differential diagnosis of OSCC, efficacy assessment and prognosis prediction.",34,26,"64,731",,Random Forest ,CNN,ML,DL,88,92,80,85,,,,,,,,,,,88,95,93.5,97.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
341,Guha 2024,How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Yes,,No,,Partial Yes,,Yes,,Yes,,No,,Partial Yes,,,,Yes,,Yes,,,,Yes,,Yes,,Yes,,Yes,,No,,Yes,
341,Guha 2024,How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.,JIREGNA OLANI KEDIDA,#341,How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.,To evaluate the diagnostic accuracy of ML/DL versus radiologists in classifying PCNSL versus GBM using MRI,Meta analysis,None,No,glioblastoma,MRI,Patients undergoing MRI scans,"(a) articles where ML/DL was used to classify PCNSL and GBM; (b) comparison of capability of ML/DL and radiologist were done; (c)sample size more than 10; 
(d) pathological confirmation of disease;
(e) availability of DICOM MR images of the tumor; (f) Diagnostic metrics reported as sensitivity and specificity; if
studies described performance using receiver operating characteristic curves, back-calculation of sensitivities and
specificities should be possible","commentaries, editorials, letters, or case reports, studies that used medical waveform data graphics and studies that evaluated
the accuracy of image segmentation. ",11,"ML/DL models demonstrate slightly better sensitivity, accuracy, and AUC compared to radiologists, while radiologists show higher specificity.",11,8,1159,,ML/DL,Radiologists,"CNN, ANN, SVM, RF, LASSO",NA,89,82,88,90,,,,,,,,,,,94,90,78,76,<0.01,<0.01,,,,,,,88,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
311,Yan 2024,Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#311,Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis,"To systematically summarize the latest
literature on AI histological grade prediction for PNETs. By performing
a meta-analysis, we aimed to evaluate AI accuracy and provide
evidence for its clinical application and role in decision making.",Meta analysis,"Natural Science Foundation of China
(82102961, 82072635 and 82072637), High-level Hospital
Construction Research Project of Heyuan People's Hospital
(YNKT202202), the Science and Technology Program of Heyuan
(23051017147335), the Science and Technology Program of
Guangzhou (2024A04J10016 and 202201011642)","The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",Other: pancreatic neuroendocrine tumors,MRI; CT scan; PET-CT Scans,"patients with pancreatic neuroendocrine
tumors",". 1) All studies about PNETs grading which trained the models using only histology (and not biopsy) as gold standard
were selected; 
2) All PNETs grading predictive models built by AI were included. 
3) Compared with physicians or models obtained
from clinical and traditional imaging characteristics; 
4) The main
research purposes of the included studies were to differentiate the
grades of PNETs; 
5) Research types: case-control studies, cohort
studies, nested case-control studies, and case-cohort studies",": 1) Only the influencing
factors were analyzed and a complete risk model was not built; 
2) guides, case reports and non-original investigations (e.g., editorials,
letters, meta-analyses and reviews); 
3) other than English and
animal studies. Any disagreements were resolved by consensus
arbitrated by a third author",416,"AI-based models, area under the curve (AUC) values, predictive value calculated.",26,20,2639,,ML,ML,"RF, SVM, LASSO","CNN, LR,RF",84.7,80.1,92.9,79.5,4.97,3.91,0.18,0.25,,,,,27.03,16.58,90,81,89.91,41.54,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
305,Chen 2024,Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,Partial Yes,,Yes,,Yes,,Partial Yes,,Partial Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,No,,Yes,,Yes,
305,Chen 2024,Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#305,Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis,to investigate the performance of ML in detecting genetic mutation status in NSCLC patients.,Meta analysis,,no known competing financial  interests or personal relationships that could have appeared to influence the work reported in this paper,lung cancer,MRI; CT scan; PET-CT Scans,"total of 128 original studies, of which 114 constructed ML models based on radiomic 
features mainly extracted from CT, MRI, and PET-CT data","(1) Studies including lung cancer patients as subjects.  
(2) Case-control studies, case-cohort studies, nested case-control 
studies, and cohort studies.  
(3) Comprehensive ML models related to mutation status of genes 
such as EGFR, ALK, KRAS, BRAF, etc.  
(4) Due to the difficulty of conducting external multicenter studies in 
ML model development, studies with no external validation were 
also included.  
(5) Studies that validate previously published models in a new cohort 
as part of ML research were also included.  
(6) Studies that were reported in English. ","(1) Meta-analyses, expert opinions, reviews, guidelines, and similar 
types of studies.  
(2) Studies in which only risk factor analysis was performed without 
constructing complete ML models.  
(3) Studies lacking the following outcome measures ROC, c-index, F1 
score, sensitivity, c-statistic, specificity, recall, precision, accuracy, confusion matrix, diagnostic fourfold table, and cali
bration curve for assessing the predictive accuracy of ML models.  
(4) Studies with a small sample size (<20 cases).  
(5) Studies solely focused on validating mature scales.  
(6) Studies examining the accuracy of single-factor prediction. ",4844," the concordance index (c-index), which reflects the overall accuracy of ML",149,114,59889,,ML,ML,"LR, SVM, CNN, RF, XGBoost, ANN","LR, CNN, SVM",78,78.5,74.5,75,,,,,,,,,,,78.3,81.4,,,0.165,0.001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
303,Song 2024,The influence of manual segmentation strategies and different phases selection on machine learning-based computed tomography in renal tumors: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#303,"The influence of manual segmentation strategies and different phases selection on machine learning-based computed tomography in renal tumors: a systematic review and meta-analysis.
"," To investigate the performance of different renal tumor manual 
delineation methods and different phases of CT on the evaluation of ML and analyzed the consensus to spread the normative methods application in renal tumors.",Meta analysis,"This work was supported by grants from the Youth Science 
Foundation of Shandong First Medical University (202201-066), the 
Science and Technology Development Plan Project of Shandong Province, China (2018GSF118209), and the Shandong Provincial Natural.
",The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.,Other: renal tumors,CT scan,"patients diagnosed with renal tumors, focusing on both benign and malignant cases","English-language papers; developed ML models; selected 
unenhanced phase (UP), corticomedullary phase (CMP), 
nephrogenic phase (NP), or excretory phase (EP) in renal 
tumors; described the details of manual delineation strat-
egies; calculated the outcomes, such as sensitivity (SE), 
and specificity (SP), accuracy (ACC), area under the curve 
(AUC) or detailed information on 2��2 contingency tab","automatic delineation strategy. Two 
reviewers (HHS and XQW) independently screened the 
titles and abstracts of the papers according to inclusion and 
exclusion criteria, and relevant papers for full content were 
downloaded and reviewed. Disagreement was discussed with 
the author (WL) and subsequently obtained an agreement 
via consensus",672,Impact of combining manual segmentation strategies with phase selection significantly impacts the performance of machine learning models in diagnosing renal tumors using CT imaging,56,23,,,ML,ML,"RF, SVM","SVM, LR",87,82,82,85,4.83,5.67,0.15,0.18,,,,,32.2,31.5,91,90,75.63,81.98,<0.05,<0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
289,Wang 2024,Standalone deep learning versus experts for diagnosis lung cancer on chest computed tomography: a systematic review.,JIREGNA OLANI KEDIDA,#289,Standalone deep learning versus experts for diagnosis lung cancer on chest computed tomography: a systematic review,To compare the diagnostic performance of standalone deep learning (DL) algorithms and human experts in lung cancer detection on chest computed tomography (CT) scans.,Meta analysis,"This study has received funding by this research was funded by Gen. and Mrs. M.C. Peng fellowship from School of Medicine, 406 National Yang Ming Chiao Tung University, MD-SY-A3-309-01, MD-SY-A3-112-C3-08, MD-SY-112-C3-09, MD-SY-112-C3-010 and MD-SY-112-C3-011; Taichung Veterans General Hospital, TCVGH-YMCT1109111; TCVGH-YMCT1119105; National Science and Technology Council in Taiwan, MOST 110-2634-F-006-022; MOST110-2221-E A49A-504-MY3; National Yang-Ming Chiao Tung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, 111 W10159; BRC
Plan 112W32101; Towards the 2030 Cross-Domain Project for Smart Healthcare and Wellness (2/2)���SMART Plan; NSTC 111-2634-F-A49-014-; NSTC 111-2634- F-006-012; Innovative Translational Center Project 112w94002; Veterans��� Taiwan Joint University Program, 113W084700. Open Access funding enabled and organized by National Yang Ming Chiao Tun",The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article,lung cancer,CT scan,"Adults with suspected or confirmed lung cancer undergoing chest CT (standard, LDCT, or HRCT).","articles relevant to DL in evaluating CT scans. Any disagreements
between the analysts were resolved by consulting a third specialist. ","Studies that focused on peri fissure nodule classification tasks focused on detection or segmentation tasks, did not involve CT, did not employ DL models, were not published in English, or did not provide contingency tables",3485,"included the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity",92,20,,,DL,Non AI,"CNN, SE-ResNet, DenseNet, U-Net, 3D-CNN, VS-CAD",,82,81,75,69,,,,,,,,,0.97,0.4,,,,,0.09,0.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
287,Castellana 2024,Radiomics and deep learning models for CT pre-operative lymph node staging in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#287,Radiomics and deep learning models for CT pre-operative lymph node staging in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.,To evaluate the diagnostic accuracy of computed tomography (CT)-based radiomic algorithms and deep learning models to preoperatively identify lymph node metastasis (LNM) in patients with pancreatic ductal adenocarcinoma (PDAC).,Meta analysis,"European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 
���HEAL ITALIA��� to Salvatore Claudio Fanni and Emanuele Neri, CUP of Universi",The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.,pancreatic cancer,CT scan,Patients with pancreatic ductal adenocarcinoma (PDAC),"(1) included patients with a diagnosis of PDAC; 
(2) developed or used radiomics models or deep learning algo��rithms to assess CT pre-operative LNM detection
(3) used histopatho��logic results as the reference standard 
(4) had sufficient data to reconstruct the 2 �� 2 contingency table to ","reviews, case reports, letters, commentaries, errata, meta-analyses and studies published only as conference abstracts. Studies were also excluded if they only presented results of combined clinical and radiomics models and if they lacked internal or external validation. ",152,Lymph node metastasis (LNM),38,8,485,,Radiomics,Deep learning,Radiomics score/nomogram,"CNN, 3D VOI DL model, others",83,83,76,76,,,,,,,,,15.7,15.7,85,85,,,0.09,0.09,0.24 (no bias detected),0.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
286,Wulaningsih 2024,Deep Learning Models for Predicting Malignancy Risk in CT-Detected Pulmonary Nodules: A Systematic Review and Meta-analysis.,JIREGNA OLANI KEDIDA,#286,Deep Learning Models for Predicting Malignancy Risk in CT-Detected Pulmonary Nodules: A Systematic Review and Meta-analysis,to assess the diagnostic performance of DL-based models for predicting the risk of malignancy in CT-detected pulmonary nodules. ,Meta analysis,This work was funded by Optellum Ltd,"JW is an employee of Optellum Ltd. Optellum Ltd holds some patents in the area of research, and funded the study. No other competing interests were reported.",lung cancer,CT scan,"8553 participants, and 9884 pulmonary nodules.",Studies were deemed eligible if they were peer-reviewed experimental or observational articles that assessed the diagnostic performance of externally validated DL-based CADx models to predict the risk of malignancy in solid or part-solid nodules.,,7116,"For each index test type (DL-based models; physician judgement alone; clinical risk models alone; Lung-RADS-based models alone), pooled estimates of area under the curve (AUC), sensitivity, and specifcity were calculated using a bivariate, random-efects approach. Deeks��� funnels were plotted to identify publication bias. To assess heterogeneity and inconsistency among the studies, ��2 statistic and I2 index values were c",69,17,8553,,DL,ML,"CNN, XGBoost, MLP","CNN, XGBoost, MLP",88,77,77,72,,,,,,,,,,,86,79,90,94,< 0.01,< 0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
283,Wang 2024,Systematic review and meta-analysis of deep learning applications in computed tomography lung cancer segmentation.,JIREGNA OLANI KEDIDA,#283,Systematic review and meta-analysis of deep learning applications in computed tomography lung cancer segmentation,to determine the strength of the current evidence regarding the accuracy and efficacy of DL models for segmenting lung cancer.,Meta analysis,"This research was funded by Gen. & Mrs. M.C. Peng Fellowship from 
School of Medicine, 406 National Yang Ming Chiao Tung University, 
MD-SY-A3-309-01, MD-SY-A3-112-C3-08, MD-SY-112-C3-09, MD-SY112-C3-010 and MD-SY-112-C3-011; Taichung Veterans General Hospital, TCVGH-YMCT1109111, TCVGH-YMCT1119105; National Science and Technology Council in Taiwan, MOST 110-2634-F-006-022; MOST 110-2221-E-A49A-504-MY3; National Yang Ming Chiao Tung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, 111 W10159; BRC Plan 112W32101; Towards the 2030 Cross-Domain Project for Smart Healthcare and Wellness (2/2) - SMART Plan; NSTC 111-2634-F-A49-014-; NSTC 111-2634-F-006-012; Innovative Translational Center Project 112w94002; Veterans��� Taiwan Joint University Program, 113W08",The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ,lung cancer,CT scan,"Adult patients with lung cancer undergoing CT imaging for tumor segmentation, particularly in radiotherapy planning contexts.",studies on adult lung cancer that integrated chest CT and DL techniques.,"articles being reviews, abstracts, posters, or conference presentations; not in English; using irrelevant imaging modalities; not using DL methodologies; having unclear dataset partitioning; and including topics not pertinent to the current meta-analysis ",1497,Performance of deep learning (DL) algorithms in tumor segmentation (measured by Dice score).,182,37,19092,,DL,DL,"U-Net, 3D CNNs, DenseUNet, nnU-Net","U-Net, 3D CNNs, DenseUNet, nnU-Net",,,,,,,,,,,,,,,,,91.55,88.93,< 0.01,< 0.01,0.3848,0.3848,78,79,101.77,2081.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
278,Fu 2024,Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,Yes,,,,Yes,,Yes,,No,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
278,Fu 2024,Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#278,Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.,To  investigates the diagnostic accuracy of ultrasound-based radiomics as a novel approach to predicting these markers.,Meta analysis,"The author(s) received no specific
funding for this work","The authors have declared
that no competing interests exist",breast cancer,Ultrasonography,Breast Cancer patients,"1. Population: patients diagnosed with BC.
2. Index test: using AI-based methods to predict the status of the key molecular biomarkers (HER2, Ki67, PR, and ER) in patients.
3. Comparator: using biopsies or surgically excised samples to determine the status of the
molecular biomarkers.
4. Outcome: Studies with enough data to predict the status of key molecular biomarkers in BC patients based on US images before surgical procedures (biopsy, excisional biopsy,
surgery)","1. Studies incompatible with the PICO criteria mentioned above.
2. Reviews (narrative, systematic, and meta-analysis), case reports, conference abstracts, comments, and letters to editors.
3. Articles in a non-English language.
4. Studies not using AI-based methods",363,"Studies with enough data to predict the status of key molecular biomarkers in BC
patients based on US images before surgical procedures (biopsy, excisional biopsy,
surgery)",23,15,11005,,"DL, Radiomics","DL, Radiomics","LR, DL,SVM,RF, NB","LASSO, LR, SVM,RF,NB",76,80,78,76,,,0.31,,,,,,,,84,81,,,0.001,0.001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
275,FedatoTobias 2024,Diagnostic capability of artificial intelligence tools for detecting and classifying odontogenic cysts and tumors: a systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
275,FedatoTobias 2024,Diagnostic capability of artificial intelligence tools for detecting and classifying odontogenic cysts and tumors: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#275,Diagnostic capability of artificial intelligence tools for detecting and classifying odontogenic cysts and tumors: a systematic review and meta-analysis.,"To evaluate the diagnostic capability of artificial intelligence (AI) for detecting and classifying odontogenic cysts and tumors, with special emphasis on odontogenic keratocyst (OKC) and ameloblastoma.",Systematic review,None,None,Other,Other,Patients with odontogenic cysts and tumors,"Studies with no restrictions on year or language that conformed to a PIRD framework question: Population (P): Humans with any odontogenic cyst or tumor; Index test (I): AI tools for identifying or classifying odontogenic cysts and tumors; Reference test (R): Panoramic and/or
CBCT images interpreted by radiologists and confirmed by histopathological analysis; and Diagnosis (D): Accuracy in detecting or classifying odontogenic cysts and tumors.","animal and in vitro research, studies that did not investigate the use of AI in cases of odontogenic cysts and tumors, studies that did not apply the reference tests (panoramic and/or CBCT), studies in which the presence or absence of lesions could not be assessed, studies not using histopathological analysis as the reference
standard for the final diagnosis of odontogenic cysts or tumors, case reports, reviews, letters, personal opinions, book chapters, and conference abstracts.",2607,Diagnostic accuracy for AI-based classification of odontogenic keratocysts (OKC) and ameloblastomas.,12,12,1480,,DL,ML,CNN,CNN,98.4,94.29,92.3,96.48,0.97,,0.85,,,,,,1.14,,97,89,93.83,,<0.001,,,,,,32.39,,89,89.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
271,Zeng 2024,Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review.,JIREGNA OLANI KEDIDA,#271,Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review.,"To identify and quantify the types of AI errors to 
better understand the consequences of implementing this technology.",Meta analysis,"CAUL and its Member Institutions. Aileen Zeng was a recipient of The Daffodil Centre Postgraduate Research Scholarship. Dr Luke Marinovich is funded by a National Breast Cancer Foundation Investigator Initiated 
Research Scheme grant (2023/IIRS0028). Prof Nehamat Houssami is 
funded through a National Breast Cancer Foundation Chair in Breast Cancer Prevention grant (EC-21-001) and a National Health and Medical Research Council Investigator Leader grant (1194410). Dr Brooke Nickel is supported by a National Health and Medical Research Council (NHMRC) Emerging Leader Research Fellowship (1194108)",The authors have no relevant financial or non-financial interests to disclose.,breast cancer,X- Ray,population of breast cancer screening with mammography,"studies included both conventional mammography and tomosynthesis, data on mammograms only were included.","- where the AI algorithm acted as an independent reader (defined as a standalone system for replacement of radiolo-gist reading, or as a pre-screen to triage whether the mammogram requires further review by a radiologist).

- Studies were excluded if more than 5% of included mammograms were incomplete; AI was used as a prediction tool (e.g. cancer subtypes, lesion characteristics or risk) or to assist radiologist reading (meaning the read was not solely from the AI algorithm); or AI was implemented for other imaging types (e.g. magnetic resonance imaging or ultra-
sound). 
-  Studies were excluded if outcomes did not include 
AI errors.",2493,"evaluates AI errors in screening mammography, focusing on diagnostic accuracy measures such as false positive proportions (FPP), false negative proportions (FNP), and heterogeneity.",7,5,447676,,AI,AI,Transpara Score 3,Transpara Score 9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.83,10.77,0.02,0.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
266,Ma 2024,Radiomics diagnostic performance for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#266,Radiomics diagnostic performance for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis.,To evaluates existing evidence on the accuracy of radiomics models for predicting LNM in esophageal cancer,Meta analysis,No,No,Other: Esophageal cancer,MRI; CT scan; PET,"ne studies met inclusion criteria, encompassing 719 patients.","(a) application of radiomics to predict LNM in 
esophageal cancer, (b) all participants had pathological 
postoperative LNM status (c) sufficient data for calcu
lating 2��2 contingency tables consisting of true positive 
(TP), false positive (FP), false negative (FN), and true 
negative (","(a) review papers, case reports, meetings, letters, abstracts,  editorials, comments, posters, and guidelines; (b) studies that did not use radiomics methods for predicting LNM; 
(c) articles with no access; (d) literature published in a language other than English; (d) not providing enough data for constructing 2��2 tables; and (e) studies that not used separate validation coh",426,"Statistical analysis involved random-effects models for pooled sensitivity, specificity, diagnostic odds ratio (DOR), and area under the 
curve (AUC). Heterogeneity and publication bias were assessed using Deek���s test and funnel p",9,9,719,,Conventional radiomics,Deep Learning Radiomics,LR,FAGNN,73,70,78,71,3.32,2.41,0.35,0.42,,,,,9.49,5.74,74,70,57.04,0,0.02,0.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
261,Jannatdoust 2024,Diagnostic accuracy of CT-based radiomics and deep learning for predicting lymph node metastasis in esophageal cancer.,JIREGNA OLANI KEDIDA,#261,Diagnostic accuracy of CT-based radiomics and deep learning for predicting lymph node metastasis in esophageal cancer,to consolidate existing knowledge on the role of CT-based radiomics and DL for predicting LNM in esophageal cancer,Meta analysis,"This research did not receive any funding from public, commercial, or nonprofit sectors","The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence 
the work reported in this paper",Other: esophageal cancer,CT scan,a total of 308 articles.,"All studies relevant to the subject of interest, presenting at least one of the discrimination statistics of CT-based radiomics and/or DL models, 
were considered for inclusion","Non-English literature, case reports, case series with fewer than five eligible patients, conference abstracts, editorial comments, and review articles were excluded from this study",308,Diagnostic accuracy of CT-based radiomics and deep learning for predicting lymph node metastasis in esophageal cancer,12,7,,,"Radiomics, DL","Radiomics, DL","SVM, RF, AdaBoost, LR, FAGNN, CNN, U-net","SVM, RF, AdaBoost, LR, FAGNN, CNN, U-net",78.7,81.2,81.8,76.2,,,,,,,,,,,87,85,68.85,22.7,AUC diff: 0.39; Sens/Spec: 0.69/0.18,AUC diff: 0.39; Sens/Spec: 0.69/0.18,p = 0.087 (Egger���s,p = 0.087 (Egger���s,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
107,ChungCYC 2024,Predicting IDH and ATRX mutations in gliomas from radiomic features with machine learning: a systematic review and meta-analysis.,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Partial yes,,Yes,,Partial Yes,,Yes,,No,,No,,Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
107,ChungCYC 2024,Predicting IDH and ATRX mutations in gliomas from radiomic features with machine learning: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#107,Predicting IDH and ATRX mutations in gliomas from radiomic features with machine learning: a systematic review and meta-analysis,"This systematic review aims to evaluate the quality and accuracy of
ML algorithms in predicting ATRX and IDH mutation status in patients with glioma through the analysis of radiomic features extracted from medical imaging",Meta analysis,This review was funded through London South Bank University (LSBU),The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest,glioblastoma,MRI; CT scan; PET,"Eleven studies involving 1,685 patients with grade I���IV g",#NAME?,#NAME?,67,"Accuracy metrics for ML reported including sensitivity, specificity and AUC",11,11,1685,,"ML, DL","ML, DL","SVM, RF, XGBoost, Boruta, BR, EC, CNN, Elastic Net, AutoML, ResNet50, C3D","SVM, RF, XGBoost, Boruta, BR, EC, CNN, Elastic Net, AutoML, ResNet50, C3D",83.1,68.2,82.8,87.4,,,,,,,,,,,94.8,84.2,32.11,25.31,0.207,0.253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
87,Emilio 2025,How reliable is artificial intelligence in the diagnosis of cholesteatoma on CT images?,Tawadod Abdelgader Abdalla Mohamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Partial yes,,Yes,,Partial Yes,,Yes,,Yes,,No,,Yes,,Includes only NRSI ,,Yes,,Yes,,No meta-analysis conducted ,,Yes,,Yes,,Yes,,Yes,,Yes,,Yes,
87,Emilio 2025,How reliable is artificial intelligence in the diagnosis of cholesteatoma on CT images?,JIREGNA OLANI KEDIDA,#87,How reliable is artificial intelligence in the diagnosis of cholesteatoma on CT images?,To explore and evaluate the burgeoning role of AI in the diagnosis of cholesteatoma by conducting a comprehensive meta-analysis of existing studies.,Meta analysis,,"Any commercial or financial relationship that might have the potential of being viewed as a conflict of interest has been disclosed for this work from any of the following organizations: National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), and other(s)",thyroid nodules,CT scan,Patients undergone to CT Scan to recognize cholesteatoma,studies had to report data about the used AI models that should recognize cholesteatoma in CT image,#NAME?,32,"Sensitivity, Specificity, Accuracy, Precision",5,3,675,,AI,AI,"Densenet201, Resnet50, MobileNetV2","MobileNetV2, Resnet50",88.45,85,93.69,95,,,,,84.73,89.45,,,,,91.5,91,11.81,11.81,>0.05,>0.05,,,,,,,92.53,91.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
60,LopesCosta 2024,Accuracy of machine learning models for pre-diagnosis and diagnosis of pancreatic ductal adenocarcinoma in contrast-CT images: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#60,"
Accuracy of machine learning models for pre���diagnosis and diagnosis 
of pancreatic ductal adenocarcinoma in contrast���CT images: a systematic review and met","To evaluate the diagnostic ability and methodological quality of ML models in detecting Pancreatic Ductal Adeno-
carcinoma (PDAC) in Contrast CT images",Meta analysis,"This research did not receive any specific grant from funding 
agencies in the public, commercial, or not-for-profit sectors.",NA,pancreatic cancer,CT scan,"Nine studies were included and 12,788 participants were evaluated"," (population): Adult patients diagnosed with pancreatic 
ductal adenocarcinoma (PDAC).
I (index test): ML techniques on contrast-enhanced 
abdominal CT images (including DL, SVM, Decision Tree 
etc.).
R (reference test): Histopathological confirmation, resec-
tion, or traditional human CT report.
D (diagnostic): Overall diagnostic accuracy, including 
sensitivity, specificity, and AUC.
Type of Studies: Observational studies, cohort studies and 
case���control trials, with no restriction of publication p","(1) No eligibility criteria: 
included cases were normal, related to non-neoplastic pan-
creatic diseases (pancreatitis, cystic lesions, lithiasis etc.) 
or other subtypes of non-PDAC cancers, only the train-
ing model was included (there was no validation or testing 
group), or the control group was composed of unhealthy 
patients or those with pancreatic lesions visualized on CT, 
(2) Studies focused only on pancreatic segmentation or non-
diagnosis, 
(3) Multiple classification articles, 
(4) Abstracts,
conference articles, preprints, review articles, retracted article or other secondary studies were also not included. ",1644,Metrics of tests were interpreted by ML algorithms.,36,9,9,,Decision Trees,CNN,Gradient Boosting decision tree,Modified ResNet,91,85,89,92,8.27,10.63,0.1,0.17,,,,,82.7,62.5,91,92,26.24,80.28,0.258,<0.001,,,,,,,88.7,88.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
56,Valizadeh 2025,Predicting lymph node metastasis in thyroid cancer: systematic review and meta-analysis on the CT/MRI-based radiomics and deep learning models.,JIREGNA OLANI KEDIDA,#56,Predicting lymph node metastasis in thyroid cancer: systematic review and meta-analysis on the CT/MRI-based radiomics and deep learning models,"consolidating evidence regarding the diagnostic accuracy of CT and MRI-based radiomics and deep learning methods for predicting cervical LNM in thyroid cancer, aiming to provide insights into their clinical applicability and future developme",Meta analysis,"This research did not receive any funding from public, commercial, or nonprofit sectors.","The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influence the work reported in this paper.",thyroid nodules,MRI; CT scan,Patients with thyroid cancer (mainly Papillary Thyroid Carcinoma - PTC). Majority female. Studies conducted in China and South Korea. Imaging: CT or MRI. Manual segmentation applied. Ages ranged roughly 38���47 ,"All studies relevant to the subject of interest, presenting at least one
of the discrimination statistics of CT/MRI-based radiomics and/or DL
models","non-English literature, case reports, case series with fewer than five eligible patients, conference abstracts, editorial comments, and review articles.",327,Diagnostic performance of CT/MRI-based radiomics and/or deep learning models for predicting cervical lymph node metastasis (LNM).,26,16,4625,,ML,AI,"LR, SVM, RF, KNN","CNN, ResNet50, DenseNet121",79.4,80.8,69.2,78.7,2.58,3.79,0.3,0.24,,,,,8.6,15.6,82,89,High,High,p = 0.037,p = 0.037,No bias in validation sets (p = 0.15); bias in training sets (p < 0.01),No bias in validation sets (p = 0.15); bias in training sets (p < 0.01),,,,,80,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
49,Wang 2025,Performance of Convolutional Neural Network Models in Meningioma Segmentation in Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.,JIREGNA OLANI KEDIDA,#49,Performance of Convolutional Neural Network Models in Meningioma Segmentation in Magnetic Resonance Imaging: A Systematic Review and Meta���An,assess the effectiveness of CNN models in segmenting meningioma using MRI.,Meta analysis,"Open Access funding enabled and organized by National Yang Ming Chiao Tung University. This research was funded by Gen. & Mrs. M.C. Peng Fellowship from School of Medicine, 406 National Yang Ming Chiao Tung University, MD-SY-A3-309-01; Taichung Veterans General Hospital, TCVGH-YMCT1109111, TCVGH-YMCT1119105; National Science and Technology Council in Taiwan, MOST 110-2634-F-006- 022; MOST110-2221-E-A49A-504-MY3; National Yang Ming Chiao Tung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, 111 W10159; BRC Plan 112W32101; Towards the 2030 Cross-Domain Project for Smart Healthcare and Well-ness (2/2) - SMART Plan; NSTC 111 2634-F-A49-014-; NSTC 111-2634-F-006-012; Innovative Translational Center Project 112w94002; National science and technology council: NSCT 111-2634-F-006-012",The authors declare no competing interests,brain cancer,MRI,"The characteristics of patients (n = 4,828) and methods used in the nine retrospective studies conducted between  2012 and 2022","nitial query across multiple databases 
yielded 321 studies: 66 from PubMed, 115 from Embase, 
and 140 from Web of Science","A screening of titles and abstracts, datasets, news pieces, or conference 
presentations rather than empirical studies; not using DL 
algorithms; featuring repeated datasets; or covering topics 
outside the scope of our meta-analysis, ",321,"Meta-analysis, subgroup analysis, and meta-regression were performed to investigate the effects of MRI sequence, CNN architecture, and training dataset size on model performance.",57,9,4828,,DL,DL,"nnU-Net, U-net, DE-Uformer, DeepLab V3+, AGU-Net, DeepMedic","nnU-Net, U-net, DE-Uformer, DeepLab V3+, AGU-Net, DeepMedic",,,,,,,,,,,,,,,,,8.75,96.28,0.67,0,,,89,88,2.34,85.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
49,Wang 2025,Performance of Convolutional Neural Network Models in Meningioma Segmentation in Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.,Ivana Maria D'Antonio,,"Performance of Convolutional Neural Network Models in Meningioma 
Segmentation in Magnetic Resonance Imaging: A Systematic Review 
and Meta���An","his sys-
tematic review and meta-analysis was conducted to explore 
the applications of current CNN models in meningioma MRI 
segmentation and guide strategies for enhancing segmenta-
",,-,The authors declare no competing interests,,MRI,"The characteristics of patients (n = 4,828) and methods used in the nine retrospective studies conducted between 2012 and 2022 are summarized in Table 1. The studies varied in terms of sample size (range: 91 patients (Hwang et al. 2022) to 1,069 patients (Lee et al. 2023)). Methodo-logically, all studies adopted a retrospective design, focus-ing on the analysis of pre-existing datasets. This approach is relevant for examining extensive patient history and outcome data over prolonged periods. The oldest dataset (2001) was obtained from a study by Kang et al. (2023) (Kang et al. 2023). ",,"An initial query across multiple databases 
yielded 321 studies: 66 from PubMed, 115 from Embase, 
and 140 from Web of Science. After removing 89 duplicate 
entries, we used EndNote to sift through the remaining 232 
articles. A screening of titles and abstracts led to the exclu-
sion of an additional 175 articles because of their irrelevance 
to our study, per the study criteria. Further scrutiny of the 
remaining 57 full-text articles resulted in the exclusion of 
48 articles (Sobhaninia et al. 2023; ���Laukamp et al. 2018) 
because of them being datasets, news pieces, or conference 
presentations rather than empirical studies; not using DL 
algorithms; featuring repeated datasets; or covering topics 
outside the scope of our meta-analysis (Tab",9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,No,,Partial yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
33,Tavanaei 2025,Performance of Radiomics-based machine learning and deep learning-based methods in the prediction of tumor grade in meningioma: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#33,Performance of Radiomics-based machine learning and deep learning-based methods in the prediction of tumor grade in meningioma: a systematic review and meta-analysis,to evaluate the performance of these models in predicting the WHO meningioma grade using imaging data,Meta analysis,"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.",The authors declare no competing interests.,brain cancer; spine cancer,MRI,"The study focuses on predicting the WHO grade of meningiomas using imaging data, including MRI","(1) studies reporting at least one performance metric for the performance of ML algorithms in predicting the tumor grade in meningioma, such as accuracy, area under the receiver operating characteristics curve (AUROC), sensitivity, or specificity;
(2) original articles involving human participants and written in English.","(1) Studies merely evaluating the performance of ML algorithms in outcome prediction, tumor detection, orsegmentation with no relevant information regarding tumor 
grading;
(2) reviews, editorials or letters, comments, and 
non-clinical studies.",299,"The overall pooled sensitivity, specificity, and AUROC of ML methods for predicting tumor grade in meningioma",32,19,15365,,ML,DL,"SVM, RF, Logistic Regression, XGBoost, Na��ve Bayes, LightGBM, Inception-V3, ","CNN, ResNet, DenseNet",85,85,87,91,6.5,9.02,0.17,0.18,,,,,,,93,92,95,76,0,0,,,,,317.69,136.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12,Tao 2025,Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis.,JIREGNA OLANI KEDIDA,#12,Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis,to evaluate the AI diagnostic accuracy for BM,Meta analysis,National Natural Science Foundation of China (NO: 82360358) and Gansu Provincial People���s Hospital Intramural Research Fund Program (NO: 21GSS,The authors declare no competing interests.,Other: tumor bone metastases,MRI; CT scan,,"1. Study Types: Cohort studies (both prospective and 
retrospective), case-control studies, and cross-
sectional studies.
2. Participants: patients with tumor BM.
3. Exposure: Diagnosis of BM based on imaging data 
(CT/MRI) using AI algorithms.
Reference Standard: Patients with a diagnosis of 
BM confirmed by histopathology, radiology, and 
clinical assessments
","1. Study Type Discrepancies: Exclusion of case reports, reviews, conference abstracts, letters to the editor, guidelines, etc. 
2. Participant Incompatibility: Exclusion of patients who did not undergo both CT and MRI. 
3. Inconsistent Exposure Factors: Exclusion of studies that did not use CT/MRI imaging data for diagnosing bone metastases. 4. Inconsistent Reference Criteria: Exclusion of studies that did not use histopathology, radiology, and clinical diagnosis as reference standards.",5300,The objective was to identify studies that developed and/or validated AI algorithms and models for detecting BM from malignancies.,20,16,,,ML,DL,"ANN, RF, SVM, NB, KNN, XGBoost, LR, VP, DT","CNN, DCNN, U-net, InceptionV3, Resnet34, Resnet101, EfficientNet-B3, MVITV2",88,89,88,89,6.41,8.11,0.13,0.14,,,,,119,58.64,93,95,47.49,87.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12,Tao 2025,Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis.,Ivana Maria D'Antonio,,"Accuracy of artificial intelligence in detecting 
tumor bone metastases: a systematic review 
and meta-analysis","To address 
these uncertainties, our research involved a comprehen
sive systematic review and meta-analysis to analyze the 
diagnostic capabilities of AI-based technologies in identi
fying BM, covering all pertinent studies",Meta analysis,"National Natural Science Foundation of China (NO: 82360358) and Gansu 
Provincial People���s Hospital Intramural Research Fund Program (NO: 
21GSS",The authors declare no competing interests.,endometrial cancer,MRI; CT scan,"Studies must report diagnostic 
performance indices of the AI algorithms, such as 
SE, SP, positive predictive value (PPV), negative 
predictive value (NPV), PLR, NLR, DOR, or 
accuracy. These metrics should help estimate the 
true negative (TN), false negative (FN), false positive 
(FP), and true positive (TP) values","We included studies that applied AI and radiomics to 
diagnose and predict BM. The inclusion criteria were as 
follows:
1. Study Types: Cohort studies (both prospective and 
retrospective), case-control studies, and cross-
sectional studies.
2. Participants: patients with tumor BM.
3. Exposure: Diagnosis of BM based on imaging data 
(CT/MRI) using AI algorithms.
Reference Standard: Patients with a diagnosis of 
BM confirmed by histopathology, radiology, and 
clinical assessments.
4. Outcomes: Studies must report diagnostic 
performance indices of the AI algorithms, such as 
SE, SP, positive predictive value (PPV), negative 
predictive value (NPV), PLR, NLR, DOR, or 
accuracy. These metrics should help estimate the 
true negative (TN), false negative (FN), false positive 
(FP), and true positive (TP) values.
","1. Study Type Discrepancies: Exclusion of case reports, 
reviews, conference abstracts, letters to the editor, 
guidelines, etc. 2. Participant Incompatibility: Exclusion 
of patients who did not undergo both CT and MRI. 3. 
Inconsistent Exposure Factors: Exclusion of studies that 
did not use CT/MRI imaging data for diagnosing bone 
metastases. 4. Inconsistent Reference Criteria: Exclusion 
of studies that did not use histopathology, radiology, and 
clinical diagnosis as reference standards.",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,,Yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2,Wang 2025,Deep Learning in Thoracic Oncology: Meta-Analytical Insights into Lung Nodule Early-Detection Technologies.,Honoria Ocagli,#2,Deep Learning in Thoracic Oncology: Meta-Analytical Insights into Lung Nodule Early-Detection Technologies.,"This review provides a comprehensive overview of the current state of AI in lung nodule detection and
its potential implications for clinical practice, policy-making, and future research. Such an
exploration can revolutionize the lung cancer screening process, optimizing early detection
and thereby affecting patient outcomes",Meta analysis,"his research was funded by the Gen. & Mrs. M.C. Peng Fellowship from the School of
Medicine, 406 National Yang Ming Chiao Tung University, MD-SY-A3-309-01; Taichung Veterans
General Hospital, TCVGH-YMCT1109111, TCVGH-YMCT1119105; the National Science and Tech-
nology Council in Taiwan, MOST 110-2634-F-006-022, MOST 110-2221-E-A49A-504-MY3; National
Yang Ming Chiao Tung University from the Featured Areas Research Center Program within the
framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan,
111 W10159; BRC Plan 112W32101; Towards the 2030 Cross-Domain Project for Smart Healthcare
and Wellness (2/2)���SMART Plan; NSTC 111-2634-F-A49-014-; NSTC 111-2634-F-006-012; Innovative
Translational Center Project 112w",The authors declare no conflicts of interest,cancer of lung,CT scan,adults with lung cancer and used chest LDCT and CT images,"We evaluated the dimensions and types of algorithms employed in these studies. 
In addition, we examined various advanced preprocessing techniques, including generative methods, lung segmentation approaches, intensity standardization, resolution adjustments,
image cropping, and data augmentation strategies.
Furthermore, we analyzed false-positive reduction, multiscale approaches employed, model input dimensions, and specific deep learning models. 
We analyzed the performance of deep learning algorithms, focusing on lesion-wise sensitivity. This performance metric was calculated to determine average lesion-wise
sensitivity across an extensive range of false-positive thresholds per scan, including 1/8,
1/4, 1/2, 1, 2, 4, and 8. This metric also reflects precision, enabling a comprehensive
assessment of the performance of deep learning models in the detection of lung nodules","
",48,Efficacy of Deep Learning Model Detection of Lung Cancer on CT Images,48,48,,,All studies,85,,,,,,,,,,,,,,,99.18,99.23,99.25,NA,0.75,,CNNs,CNNs,,,,,,,,,,,,,Yes,,Yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
